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Resumo 
 
 A Diabetes Melitos é uma doença de grande prevalência a nível 
mundial e os seus mecanismos fisiopatológicos não são ainda totalmente 
conhecidos.  
 Actualmente, a terapêutica seguida em casos de Diabetes Melitos é 
eminentemente sintomática consistindo na administração de insulina nos 
casos de Diabetes Melitos tipo 1 ou quando se verifica a falência das células 
beta do pâncreas de pacientes com Diabetes Melitos tipo 2, ou no controlo da 
glicemia nos casos de Diabetes Melitos tipo 2.  
 A hiperglicemia, fenótipo característico desta patologia, produz efeitos 
negativos no organismo a longo prazo, levando à modificação estrutural e 
funcional de vários proteínas, afectando,  deste modo, diversos processos 
moleculares em que intervêm estas proteínas.  
 Os dois tipos Diabetes Melitos influenciam, de forma diferenciada, a 
expressão de diversas proteínas, produzindo efeitos ao nível das vias de 
sinalização celular e nos processos biológicos celulares. 
 Consequentemente, conhecer as características moleculares dos dois 
tipos de Diabetes Melitos permite o desenvolvimento de técnicas diagnósticas 
e terapêuticas mais precoces e eficazes específicas para cada uma delas. 
 Tendo como base o proteoma da cavidade oral, denominado Oraloma, 
este estudo pretende actualizar os dados provenientes de estudos de 
proteómica da cavidade oral de pacientes com os dois tipos de Diabetes 
Melitos e estudá-los com recurso a ferramentas bioinformáticas que permitem 
a caracterização das proteínas indexadas.  
 Dado a cavidade oral ser um ecossistema, é indissociável dos 
microrganismos que nele existem. Consequentemente, é objectivo deste 
estudo anotar as estirpes de microrganismos identificados pela literatura 
actual, por forma a caracterizar de forma mais completa este aspecto 
molecular da cavidade oral. 
 
Palavras-chave: diabetes, oraloma, proteómica, bioinformática
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Abstract 
  
 Diabetes Mellitus is a disease with high prevalence worldwide with 
pathophysiological mechanisms not yet fully understood. 
 Nowadays, the therapeutical approach of Diabetes Mellitus is mainly a 
symptomatic one based on insulin administration to type 1 Diabetes Mellitus 
patients and type 2 Diabetes Mellitus patients with no funtional pancreatic 
beta-cells or the serum glucose concentration control in type 2 Diabetes 
Mellitus patients. 
 Hyperglykemia is a carachteristic phenotype of this pathology, it brings 
long-run negative effects on the organism due to its role on modifying proteins 
structure and function affecting the organism's integrity. 
 Both Diabetes Mellitus types influence, on different ways, protein 
expression hence leading to changes on the molecular signaling pathways 
and biologic process of the cells. 
 Thereafter, to know the molecular aspects of both Diabetes Mellitus 
types is key to develop better, more efficient and precocious diagnostic and 
therapeutic tecniques. 
 Based on the oral proteome,  namely the oralome, this study aims to 
update data from the pre-existing oral proteomic studies on both types of 
Diabetes Mellitus and to study them using bioinformatic tools which allow 
these proteins carachterization.  
 Being an ecossystem, the oral cavity is inseparable of the 
microrganisms which inhabit in it. Therefore, another aim of the present study 
is to annotate the microrganisms species identified by the current scientific 
literature, in order to charactherize in a more complete way this molecular 
aspect of the oral cavity. 
 
Keywords: Diabetes, oralome, proteomics, bioinformatics 
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1 Introdução 
1.1 Diabetes Melitos  
 
 De acordo com a Organização Mundial de Saúde, a Diabetes Melitos é 
uma patologia crónica que ocorre quando o pâncreas não produz insulina 
suficiente para suprir as necessidades do organismo ou quando, apesar de o 
pâncreas produzir insulina, o organismo não consegue utilizar eficazmente a 
insulina produzida. Como corolário desta definição, é correto afirmar que a 
Diabetes Melitos é um grupo de distúrbios metabólicos que compartilham o 
fenótipo de hiperglicemia. 
 A principal causa de morte em pacientes diabéticos são complicações 
das artérias coronárias, geralmente o enfarte do miocárdio1. 
1.2 Epidemiologia da Diabetes Melitos 
 
 A prevalência desta patologia atingiu proporções epidémicas, 
traduzindo-se, segundo estimativa da Organização Mundial de Saúde em 
2008, em cerca de 200 milhões de indivíduos afetados. Se se mantiverem os 
padrões atuais, estima-se que até 2050 hajam 500 000 000 de indivíduos 
diabéticos. 
 Existem dois tipos mais prevalentes de Diabetes Melitos, o tipo 1 e o 
tipo 2. 
A Diabetes Melitos tipo 2 é a mais prevalente, consistindo em cerca de 85 a 
90% de todos os casos de Diabetes Melitos; sendo que a Diabetes Melitos 
tipo 1, uma doença autoimune em que são produzidos anticorpos para a 
enzima GAD (glutamic acid decarboxylase) acabando por atacar e destruir as 
células β pancreáticas produtoras de insulina, é menos comum. 
 Apesar de haver uma componente genética na incidência de Diabetes 
Melitos tanto de tipo 1 como de tipo 2, a Diabetes Melitos tipo 2 é 
influenciada, em cerca de 10% de indivíduos diabéticos deste tipo, por fatores 
individuais de risco tais como a obesidade e o estilo de vida sedentário.  
 A prevalência de Diabetes Melitos a nível mundial é crescente, mais 
marcada em países em desenvolvimento2,3. 
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1.2.1 Patogénese da Diabetes Melitos tipo 1 
 
Uma redução no número de células β provoca um défice quase absoluto de 
insulina. Este tipo de Diabetes Melitos desenvolve-se normalmente na 
infância, tornando-se mais severo na puberdade4. 
 A Diabetes Melitos tipo 1 causa grandes distúrbios metabólicos e 
fisiológicos. O défice de insulina não permite a entrada de glucose do sangue 
para a célula, isto provoca um estado de inanição metabólica.4,5 
Consequentemente a baixa concentração de insulina sanguínea aliada a uma 
alta concentração de glucagão e epinefrina culminam na lipólise de 
triglicerídeos do tecido adiposo5. Os ácidos gordos libertados são 
transportados na corrente sanguínea pela albumina e sofrem β-oxidação a 
nível intracelular. Os resultados desta reacção são a acetil-coenzima A e 
enzimas reduzidas (NADH e FADH2), utilizadas no ciclo TCA e na 
fosforilação oxidativa nos tecidos. A quantidade de acetil-coenzima A 
produzida a partir de ácidos gordos é superior à que pode ser metabolizada, 
o excedente não-metabolizado é transformado em corpos cetónicos (aceto-
acetato, hidroxibutirato e acetona). A continuada formação de corpos 
cetónicos produz um estado de cetoacidose (acidose metabólica), que por 
sua vez provoca alteração no balanço electrolítico do organismo (diurese 
osmótica) levando o indivíduo a excretar volumes significativos de urina, 
devido à presença de glucose no fluido glomerular renal. Esta patologia pode 
ser fatal se não tratada, consistindo o tratamento na administração de 
insulina 4,5.  
 Existe também uma susceptibilidade genética na Diabetes Melitos 
tipo1, cerca de 95% dos pacientes brancos com Diabetes tipo 1 possuem 
tanto o alelo HLA-DR3 ou HLA-DR4 ou mesmo ambos4. É sugerido que 
alterações na molécula HLA classe II pode produzir efeitos ao nível do 
reconhecimento nos receptores de células T e modificar também a 
apresentação de antigénios. 
 Ainda que não estejam definidos quais, existe sugestão da 
possibilidade de certos factores ambientais despoletarem os fenómenos de 
autoimunidade da Diabetes tipo 1, tais como vírus, retrovirus e toxinas 4. 
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1.2.2 Patogénese da Diabetes Melitos tipo 2 
 
 Na patogénese da Diabetes Melitos tipo 2, não existe evidência de 
fenómenos autoimunes como na Diabetes Melitos tipo 1, embora o estilo de 
vida e a predisposição genética sejam mais preponderantes no 
desenvolvimento da doença. 
 Na Diabetes Melitos tipo 2 existem dois defeitos metabólicos 
característicos:  diminuição da secreção de insulina pelas células β e na 
resistência dos tecidos à insulina. 
 No início da sua patogénese, não se verifica qualquer diminuição na 
secreção de insulina, contudo o padrão pulsátil e oscilatório da sua secreção 
é perdido. Isto demonstra alterações ao nível da resposta das células β à 
hiperglicemia, ainda não ocorrendo modificações na síntese de insulina. 
 A contínua exposição a elevados níveis de glucose e de ácidos gordos 
livres leva a uma hipersensibilização das células β do pâncreas culminando 
na sua apoptose por consequência do stress causado pelos ácidos gordos 
livres ao nível do retículo endoplasmático (processo que depende de NF-κB e 
Óxido nítrico)6. 
 A resistência à insulina resulta de dois fatores, diminuição do número 
de receptores de insulina na membrana celular e a cascata de sinalização 
intracelular após ligação da insulina no receptor estar comprometida4. 
1.2.3 Patogénese das complicações da Diabetes Melitos 
 
 Ambos os tipos de Diabetes Melitos possuem as mesmas 
morbilidades, nomeadamente microangiopatia, retinopatia, nefropatia e 
neuropatia. Á luz da literatura actual, estas complicações advêm da 
hiperglicemia. Quando a hiperglicemia está controlada, estas complicações 
são menos frequentes. 
Duas razões principais estão na génese destas complicações em pacientes 
diabéticos, a glicosilação não-enzimática e a hiperglicemia intracelular e os 
seus efeitos na via de sinalização dos polióis. 
 No que concerne a glicosilação não enzimática, esta define-se como a 
ligação química reversível que ocorre entre a glucose e o grupo amina de 
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uma proteína sem o auxílio de enzimas. Os produtos de reacção da 
glicosilação não-enzimática envolvem proteínas como o glicogénio e outras 
da matriz extracelular que posteriormente sofrerão modificações estruturais 
tornando a ligação proteína-glicose irreversível. Quando a glicosilação da 
proteína se torna irreversível origina os denominados produtos avançados de 
glicosilação ou AGE's (advanced glycosilation end-produts) que dado as suas 
características bioquímicas (a adição de açúcar à sua estrutura altera-a e 
com isso a sua função) são potencialmente patogénicos7. 
 Os AGE's ocorrem não apenas com proteínas mas também com 
lípidos e ácidos nucleicos7. Quando ocorrem com proteínas como o 
glicogénio, formam ligações cruzadas entre os polipéptidos da molécula de 
glicogénio e no processo aprisionam proteínas plasmáticas ou intersticiais7. 
Quando tal ocorre em grandes vasos sanguíneos, por exemplo, aprisionam 
lipoproteínas de baixa densidade que leva à deposição de colesterol 
promovendo a aterogénese7. Em capilares como os glomerulares renais, a 
albumina liga-se à membrana basal glicosilada provocando o seu 
espessamento, característico em microangiopatia diabética7. Como os AGE's 
resistem à digestão proteolítica, dificultam a remoção de proteínas e as 
ligações cruzadas que formam aumentam a deposição de proteínas7. De 
facto, a ligação cruzada provocada pelos AGE's entre as proteínas da matriz 
extracelular impede a interacção destas proteínas com outros componentes 
da matriz extracelular provocando defeitos funcionais e estruturais7. 
 Os AGE's possuem a capacidade de se ligar aos receptores de vários 
tipos de células tais como: 
 células endoteliais, 
 monócitos 
 linfócitos, 
 macrófagos 
 células mesangiais. 
 Esta ligação provoca efeitos biológicos dependendo do tipo de célula. 
Nos monócitos promove a sua migração, nos macrófagos a secreção de 
factores de crescimento e citocinas. Também aumentam a permeabilidade 
das células endoteliais, aumentam a actividade procoagulante de macrófagos 
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e células endoteliais e provocam o aumento de produção de matriz 
extracelular por parte dos fibroblastos e do músculo liso. 
 A hiperglicemia intracelular ocorre em tecidos que não necessitam de 
insulina para captar glicose do meio extracelular, como tecidos nervosos, 
tecidos da córnea,  capilares, rins. Em situações de hiperglicemia, grandes 
quantidades de glicose entram para o meio intracelular e são modificados 
enzimaticamente formando sorbitol e posteriormente frutose. Os elevados 
níveis de sorbitol e frutose intracelular promovem um influxo aumentado de 
água levando à turgescência celular provocando lesões celulares osmóticas. 
Em tecidos como os da córnea, esta turgescência provoca opacidade e um 
aumento de volume. Os níveis intracelulares elevados de sorbitol 
comprometem a função das bombas de iões lesando as células de Schwann 
e os perícitos dos capilares da retina, resultando em neuropatia periférica e 
em microaneurismas da retina. O tratamento com inibidores da enzima que 
modifica a glicose em sorbitol, a aldose redutase, parece inibir o 
desenvolvimento de neuropatias e cataratas4. 
1.2.4 Sintomatologia da Diabetes Melitos 
 
 A sintomatologia da Diabetes Melitos é semelhante para os dois tipos, 
contudo no caso da Diabetes Melitos tipo 1 os sintomas podem surgir 
subitamente ao passo que na Diabetes Melitos tipo 2 podem aparecer mais 
tardiamente sendo o diagnóstico efectuado anos após o onset.  
Os sintomas desta patologia podem compreender alterações na visão, 
poliúria, polidipsia, fome, perda de peso e fadiga1. 
1.2.5 Tratamento da Diabetes Melitos 
 
 A administração de insulina é o tratamento preferencial em casos de 
Diabetes Melitos tipo 1. Está clinicamente comprovado que o controlo dos 
níveis séricos de glicose em pacientes com Diabetes Melitos tipo 1 reduz a 
incidência das principais complicações desta patologia, tais como  a 
retinopatia, nefropatia e a neuropatia8. 
 No que concerne o tratamento da Diabetes Melitos tipo 2 esta consiste 
fundamentalmente no controlo da dieta e no exercício físico, não sendo tão 
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complexa como nos casos de Diabetes Melitos tipo 18. Neste tipo de 
Diabetes Melitos são utilizados hipoglicemiantes orais para controlar os níveis 
séricos de glicose, combatendo a resistência à insulina por parte das células 
do organismo do paciente diabético; são também administradas estatinas de 
modo a prevenir complicações ateromatosas8. A diminuição da pressão 
sanguínea demonstra melhorar a eficácia do tratamento da Diabetes Melitos 
tipo 28. 
 Nenhum dos tratamentos atualmente em vigor vai além do controlo 
glicémico por parte do paciente, não tendo em conta as redes de interação 
moleculares que conduzem às complicações a longo prazo, responsáveis 
pela maior morbilidade destas patologias. Urge, pois, esclarecer os 
mecanismos moleculares de desenvolvimento dstas complicações. 
1.3 Interesse e desafios da utilização da saliva como fluido de 
diagnóstico 
 
 A saliva tem-se destacado como um potencial fluido de diagnóstico 
nos últimos anos dado apresentar certas vantagens relativamente a outros 
testes e exames de diagnóstico. O diagnóstico utilizando saliva não é 
invasivo, requer pouca ou nenhuma qualificação (podendo a sua colecção ser 
feita pelo próprio paciente), a saliva possui marcadores presentes igualmente 
no sangue, pode vir a ser uma alternativa em pacientes pouco colaborantes 
ou em que a colheita de sangue seja mais complicada, pode ser utilizada 
para determinar concentrações farmacológicas em pacientes e a presença de 
substâncias ilícitas no organismo de um indivíduo9,10. 
 Contudo, apesar das vantagens enumeradas, certas moléculas 
difundem-se mais facilmente na saliva que outras dado as suas 
características fisico-químicas; moléculas lipofílicas difundem-se mais 
rapidamente que moléculas lipofóbicas9. Outro obstáculo que a utilização da 
saliva enfrenta reside no facto de o seu fluxo ser variável de indivíduo para 
indivíduo e no mesmo indivíduo devido a múltiplos factores. Pacientes com 
doenças sistémicas, sujeitos a radioterapia e/ou polimedicados apresentam 
diferentes taxas de secreção por comprometimento das glândulas salivares9.  
 7 
 No que concerne a variabilidade salivar, estudos recentes de 
proteómica salivar demonstram que a variabilidade salivar se deve mais às 
diferenças inter-individuais que às diferenças intra-individuais11. Outro factor 
que pode ter influência é o momento de colheita (altura do dia), existem 
estudos que defendem que a quantidade relativa de proteínas se mantém 
constante durante o dia11 e outros estudos que afirmam que a concentração 
relativa de proteínas na saliva varia de forma constante e padronizada ao 
longo do dia12.  
1.4 O oraloma da Diabetes Melitos tipo 1 e 2 
 
 O oraloma, enquanto fisioma da cavidade oral, é o conjunto de 
proteínas presentes nesta cavidade e das suas características 
moleculares.13,14  
 Estabelecer o oraloma de uma determinada patologia passa por 
esclarecer os mecanismos moleculares alterados como consequência dessa 
situação.. Para descrever o oraloma é necessário recorrer às ciências 
ómicas, proteómica, transcriptómica, metabolómica, genómica, interatómica, 
entre outros. 
 Actualmente são ainda escassos os estudos de proteómica aplicada à 
caracterização do oraloma da Diabetes Melitos tipo 1, havendo mais estudos 
nesta área a descrever o oraloma da Diabetes Melitos tipo 2. 
 
1.4.1 O Oraloma da Diabetes Melitos tipo 1 e 2 - estado da arte 
 
 Até à data do início do presente estudo, estavam indexadas 15 
proteínas15 no oraloma da Diabetes Melitos tipo 1 e 445 proteínas referentes 
ao oraloma da Diabetes Melitos tipo 216,17. 
 As 15 proteínas quantificadas no oraloma da Diabetes Melitos tipo 1 
envolvem maioritariamente processos biológicos imunológicos, envolvendo 
as vias de sinalização de citocinas. 
 Ao contrário do que se verifica na Diabetes Melitos tipo 1 onde ainda 
são relativamente poucos os estudos de proteómica efectuados, existem 445 
proteínas indexadas como alteradas no oraloma da diabetes Melitos tipo 2. 
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Deste universo de proteínas, os processos biológicos mais afectados são os 
processos metabólicos da glicose (havendo uma notória sobre-regulação das 
proteínas agonistas da gluconeogénese) e os processos biológicos de 
resposta a estímulos dos quais resulta uma sinalização intra-celular alterada, 
coroborando o facto de as vias de sinalização em que a insulina intervem 
estarem comprometidas. 
 
1.5 Ferramentas bioinformáticas para o estudo do oraloma 
 
 Os dados gerados pelos vários estudos de proteómica que descrevem 
o oraloma de pacientes diabéticos necessitam, à semelhança de outros 
estudos aplicados a outras patologias,  de ser integrados e sistematizados de 
modo a poderem ser modelados e interpretados, possibilitando outras 
inferências. O que se verifica é que existe uma grande quantidade de 
resultados dispersos na literatura carecendo de integração e interpretação 
como um todo e não em separado. 
 Nesse sentido, existe o OralCard18, uma ferramenta bioinformática que 
consiste num repositório que indexa os dados de diversos estudos de 
proteómica da cavidade oral a partir de anotações manuais. 
 Os dados obtidos através da revisão da literatura podem, 
posteriormente, ser interpretados com recurso a outras ferramentas 
bioinformáticas como o PANTHER19 e o STRING20 
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2 Objectivos 
 
 O presente trabalho pretende, após revisão da literatura, reunir e 
integrar numa só plataforma os resultados dos diversos estudos de 
proteómica da cavidade oral referentes ao oraloma do paciente diabético, 
contribuindo através do estudo e análise in silico de tal informação para um 
melhor conhecimento dos mecanismos patogénicos dos dois tipos de 
Diabetes Melitos. Deste modo, foram objectivos deste trabalho: 
 rever a literatura actual de estudos de proteómica da cavidade oral do 
paciente diabético; 
 anotar manualmente a informação proveniente da revisão de artigos 
científicos, considerada essencial para interpretar os dados de 
proteómica; 
 atualizar o OralCard com a  informação anotada; 
 analisar in silico os dados obtidos através de ferramentas 
bioinformáticas; 
 registar e analisar as diferenças entre os dois tipos de Diabetes 
Melitos verificadas nas diversas ontologias génicas; 
 correlacionar os dados obtidos e estudados com os aspectos clínicos 
da patogénese  e patofisiologia da Diabetes Melitos 
 anotar todos os microrganismos identificados pela literatura científica 
presentes na cavidade oral de pacientes com os dois tipos de Diabetes 
Melitos 
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3 Material e Métodos 
 Por forma a alcançar os objectivos propostos foi seguida a 
metodologia explicada neste capítulo. 
Iniciou-se pela revisão da literatura e recolha de dados específicos quanto a 
proteínas alteradas nos casos de Diabetes Melitos tipo 1 e 2. 
 Numa segunda fase, a informação obtida foi analizada e interpretada 
com recurso a ferramentas bioinformáticas. 
3.1 Atualização do Oraloma da DMT1 e DMT2 
 
 O Oraloma, que se encontra reunido no OralCard, espelha a fisiologia 
molecular da cavidade oral e tem por base a integração de informação 
proveniente das ciências ómicas tais como a genómica, transcriptómica, 
proteómica, interactómica e metabolómica. 
 Apesar do Oraloma já integrar informação referente aos dois tipos de 
Diabetes Melitos, tal carece de revisão e atualização constante uma vez que 
desde a última revisão surgiram mais estudos de proteómica salivar em 
pacientes diabéticos. 
 Sabendo que proteínas se encontram alteradas em cada tipo de 
Diabetes Melitos é possível comparar que vias de sinalização podem estar 
alteradas e que influência podem estas ter no ecossistema oral. Assim, foi 
efectuada uma revisão da literatura existente, de modo a atualizar o Oraloma 
de acordo com os mais recentes estudos de proteómica da cavidade oral. 
 Desde a última revisão do Oraloma13, mais estudos de proteómica da 
cavidade oral foram efectuados.  
De modo a atualizar o Oraloma, recorreu-se ao arquivo digital de artigos 
científicos PubMed21 com a seguinte fórmula de pesquisa:  
((("DMT1" OR "DMT 1" OR "diabetes Melitos Type 1") AND (saliva* OR oral) 
AND (protein OR proteomics) NOT treatment AND ("last 10 years"[PDat]))) 
AND ("last 10 years"[PDat]) cingida a estudos respeitantes a seres humanos 
e efectuados nos últimos 10 anos, para pesquisar literatura referente à 
Diabetes Melitus tipo 1. Foram considerados resultados até Janeiro de 2013, 
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inclusive. 
 Foram obtidos 119 resultados dos quais foram selecionados 14 artigos 
científicos15,22–34 contendo informações relevantes quanto às proteínas 
encontradas alteradas em pacientes com Diabetes Melitos tipo 1.  
 A mesma metodologia foi utilizada para pesquisar informação 
molecular oral sobre pacientes com Diabetes Melitos tipo 2. Foi utilizada a 
seguinte fórmula de pesquisa:  
(DMT2) OR (DMT 2) OR (diabetes Melitos type 2) OR (type 2 diabetes 
Melitos) OR (non insulin dependent diabetes Melitos) AND (SALIV* OR oral) 
AND (proteome OR peptide OR protein OR proteomic) restringida a estudos 
efectuados entre 1/1/1997 e 31/01/2013 (dia em que foi efectuada a 
pesquisa) em seres humanos. 
 Foram obtidos 4323 resultados, dos quais foram selecionados 19 
artigos científicos2,16,17,23,35–49. 
 Os artigos selecionados foram revistos e a informação contida foi 
anotada em tabelas de Microsoft Excel de modo a organizar a informação 
quanto à identificação das proteínas identificadas, proveniência histológica da 
amostra, quantificação da alteração registada, desenho do estudo e 
respectivos critérios de inclusão/exclusão de indivíduos e hábitos sociais da 
população estudada. 
3.2 Caracterização do Oraloma da DMT1 e DMT2 
 
 Após a revisão da literatura científica mais atual quanto às proteínas 
que se encontram alteradas na cavidade oral de um paciente diabético, foi 
necessário anotar, catalogar e integrar essa informação de modo a 
possibilitar o estudo in silico do oraloma do paciente diabético. 
 Foram utilizadas técnicas algébricas e computacionais para estudar o 
conjunto das proteínas encontradas e assim comparar de que forma, as 
mesmas, podem influenciar o ecossistema oral nos dois tipos de diabetes. 
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3.2.1 Anotação dos dados obtidos na revisão da literatura 
 
 Muita informação relevante, proveniente de estudos de proteómica, 
referente ao oraloma do paciente diabético, encontra-se dispersa. Sendo um 
dos objectivos do presente trabalho reunir e integrar esses dados por forma a 
conseguir estudá-los in silico e compreender em que nível o ecossistema oral 
espelha os mecanismos e condições patofisológicas dos dois tipos de 
Diabetes Melitos. 
 Consequentemente, para efetuar este registo foi utilizado o software 
Microsoft Excel versão 14.0. Este software permite a realização de cálculos 
na própria folha de registo e possui uma vasta biblioteca de funções 
algébricas que podem ser utilizadas para o estudo dos valores observados.  
 O conjunto das proteínas em estudo foi organizado em tabela, onde se 
discriminaram diferentes características da proteína e do estudo que a 
identificou. 
 A informação anotada é idêntica à que é utilizada noutros trabalhos 
semelhantes por forma a estandardizar a metodologia de recolha de 
informação e permitir a sua posterior inclusão no repositório do Oraloma 
humano, o OralCard.  
 Para registar os dados provenientes da revisão da literatura, utilizou-se 
o programa Microsoft Excel 14.0. Foi preenchida uma tabela-base de 
Microsoft Excel cujas colunas correspondem a entradas de formulário para 
preenchimento conforme a informação obtida. 
 Na figura 1 estão enumeradas as colunas utilizadas. 
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UniProtKB 
AC 
Name Parotid Parotid 
exossome 
SM/SL Minor 
Whole 
Saliva 
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fluid 
Mucosa Tongue Health Disease 
(OMIM ID or Disease 
Database) 
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(MeS
H ID) 
Regulation Age 
Gro
up 
Gender Social 
Habit
s 
Methods of 
sampli
ng 
Methods of 
analys
is 
Type of 
study 
PTM Biomarker 
Citation 
(N
CBI 
ID) 
Obs 
Figura 1 - - Campos de informação anotada manualmente para cada uma das proteínas 
identificadas.  1-identificação da proteína; 2-proveniência da proteína; 3-proteína presente em 
ind. saudáveis; 4- identificação da doença; 5-Regulação; 6- Caracterização da população 
estudada; 7- Metodologia do estudo; 8- proteína com modicações pós-transcripcionais; 9-
proteína identificada como biomarcador da patologia; 10 - Código NCBI do artigo, 11- 
Observações, informações adicionais. 
 Durante a revisão da literatura sempre que surge uma proteína digna 
de registo são preenchidos os campos representados na Fig. 1. 
Inicia-se a anotação por identificar a proteína através do seu código unívoco, 
o código Uniprot KB50 e o seu nome (Fig.1-1); regista-se igualmente a 
proveniência da amostra onde a proteína foi identificada e refere-se se existe 
informação se a proteína anotada se encontra em indivíduos saudáveis(Fig.1-
2 e 3). De modo a corresponder a proteína anotada a uma patologia em 
específico preenchem-se ambos os códigos OMIM e MESH da doença(Fig.1-
4). Se houverem dados concretos quanto à quantidade da proteína na 
amostra, anota-se o valor da regulação, cujo cálculo se encontra explicado no 
ponto seguinte (Fig.1-5). Interessa igualmente registar o tipo de população 
estudado no artigo de onde se retirou informação da proteína (Fig.1-6), assim 
como a sua metodologia de colheita e análise de amostras (Fig.1-7). É 
possível registar se a proteína anotada apresenta modificações pós-
traducionais (Fig.1-8) ou se foi se foi sugerida como biomarcador para a 
1 1
2
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2
1 
2
1 
2
1 
2
1 
2
1 
2
1 
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1 
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doença em estudo (Fig.1-9). Por último anota-se o código NCBI do artigo a 
partir do qual culminou a anotação (Fig.1-10) e, se necessário regista-se 
algum tipo de informação adicional não contemplado pelos campos 
anteriores, preenchendo-se o campo destinado a observações (Fig.1-11). 
3.2.1.1 Cálculo da regulação da proteína 
 Nos estudos selecionados, cada proteína, na maior parte dos casos, 
foi analisada e quantificada tanto em diabéticos como no grupo controlo. De 
modo a quantificar a sua alteração, ou seja, a sua regulação, recorreu-se ao 
cálculo de "fold change". Este cálculo  permite obter a variação de um valor 
inicial para um final, neste caso de um controlo saudável para um diabético 
tipo 1 ou tipo 2. Quando o resultado do “fold change” é inferior a 1, utiliza-se o 
negativo do seu inverso ou seja: 
Se o controlo for 80 e o paciente diabético tiver 20 o “fold change” será: 
20/80= 0,25   o inverso do negativo significa que: 
-(1/(20/80)=-4  
ou seja, 4 vezes menos. Este cálculo facilita a perceção da variação da 
quantidade (ou atividade) de uma proteína na doença em relação ao controlo 
saudável. 
 Este cálculo foi aplicado a todas as proteínas cujos estudos 
mencionavam valores do paciente diabético e do controlo. 
O "fold change" permite então a percepção e quantificação da alteração de 
uma proteína entre o controlo saudável e o paciente diabético, facilitando a 
interpretação das alterações moleculares observadas entre os estados de 
saúde e de doença. 
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3.2.2 Caracterização segundo ontologias  
 
 As proteínas estudadas foram classificadas quanto à sua função 
molecular, processos biológicos em que intervêm e vias de sinalização 
afectadas, através da ferramenta PANTHER19,51 (http://www.pantherdb.org). 
Esta ferramenta bioinformática possibilita a classificação de genes e 
proteínas de acordo com as funções que desempenham e a sua relação 
evolutiva, baseando-se em dados científicos experimentais publicados e pela 
inferência de revisores especializados, o que permite prever funções mesmo 
quando não haja evidência experimental direta.  
 Para tornar estas inferências o mais atualizadas e exatas  possível, o 
PANTHER utiliza dados computacionais e revisão manual à medida que mais 
dados são gerados e acumulados. 
 O input de dados no PANTHER faz-se do respetivo código 
UniprotKB50. É igualmente possível introduzir uma lista de proteínas 
introduzindo os respetivos códigos UniprotKB em simultâneo, estudando as 
proteínas por grupos (figura 2). Para este estudo foram criadas sete listas no 
PANTHER, uma com o total das proteínas anotadas no Oraloma e duas 
outras listas com as proteínas alteradas em pacientes com Diabetes tipo 1 e 
2 (e respectivas listas das proteínas sub e sobre reguladas em cada tipo de 
Diabetes Melitos).  
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3.2.2.1 Classificação segundo processos biológicos, funções 
moleculares e vias de sinalização 
 
 Após introdução dos códigos UniprotKB e as listas de cada tipo de 
Diabetes Melitos criadas recorre-se ao PANTHER para classificar cada grupo 
de proteínas (Oralome, Diabetes Melitos tipo 1, Diabetes Melitos tipo 2) de 
acordo com o processo biológico em que participam e com as funções 
moleculares que desempenham. 
 O mesmo procedimento foi utilizado para as 3 listas e começando-se 
por selecionar uma das listas. Tomemos como exemplo a Diabetes Melitos 
tipo 1. Após clicar em submeter, e de acordo com os critérios selecionados, o 
PANTHER irá gerar uma lista com todos os genes de onde as proteínas em 
estudo são provenientes e a informação quanto a funções moleculares e 
processos biológicos em colunas. 
 Nesta lista (Figura 3) existe a opção de mostrar a informação em 
gráfico circular e de acordo com várias ontologias (função molecular, 
processo biológico, classificação proteica, localização celular e via de 
Campo de introdução 
dos códigos UniprotKB 
 
Listas de códigos 
UniprotKB já criadas 
 
Figura 2 - Campo de introdução de dados por grupo no PANTHER. 
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sinalização). 
 
 
Figura 3 - Metodologia para criar gráficos circulares. MF- Molecular Funtion, BP - Biological 
Process, CC - Celular Component, PC - Protein Class, utilizando a ferramenta PANTHER. 
Quando já se encontra numa vista de gráfico circular pode-se alterar a 
ontologia como explicado na figura 4: 
 
 
 
 
 
 
 
 
 
 
 
Após gerar 
as listas no 
Figura 4 - Gráfico circular representando os processos biológicos onde estão 
presentes as proteínas alteradas nos pacientes com Diabetes Melitos tipo 1, 
segundo a ferramenta PANTHER. 
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PANTHER é possível exportar a informação relativa a cada uma das 
ontologias em ficheiro .txt; o conteúdo do ficheiro exportado é importado para 
uma folha de cálculo do Excel para posterior estudo. 
3.2.3 Interpretação da Interactómica das proteínas alteradas 
 Após registar que proteínas se encontram alteradas nos dois tipos de 
Diabetes Melitos, em que funções moleculares e processos biológicos 
intervêm, interessa interpretrar a rede interatómica formada por essas 
proteínas. 
 A interatómica é a ciência que estuda a relação e interação de 
biomoléculas entre si, neste caso: proteínas. 
 Existe uma ferramenta bioinformática, nomeadamente o STRING20,52–
54(http://string-db.org/), que permite inserir todos os códigos UniprotKB de 
cada tipo de Diabetes Melitos em simultâneo e gerar uma visualização 
esquemática da rede interatómica das proteínas em estudo.  
 O STRING (Figura 5) permite gerar estas redes de interatómica 
baseando-se em quatro fontes de informação: 
 dados de genómica 
 dados experimentais directos 
 co-expressão 
 text mining 
 Actualmente o STRING encontra-se na sua versão 9.05 e possui 
informação quanto a 5 214 234 proteínas provenientes de 1133 organismos. 
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Figura 5 - Página de rosto da ferramenta bioinformática STRING, para estudos de interatómica 
 
No separador "Multiple Names" (Figura 6) colocam-se todos os códigos 
Uniprot de um grupo de proteínas a estudar, neste caso a Diabetes Melitos 1 
ou 2; introduzidos os códigos UniprotKB clica-se em "GO!". 
 
Figura 6 - Página de “input” da ferramenta bioinformática STRING mostrando a introdução das 
proteínas alteradas em Diabetes melitos Tipo 2. 
Após clicar em "GO!" aparecerá a lista de todas as proteínas a integrar a rede 
de interatómica. Em caso de ambiguidade, terá de se proceder à identificação 
manual das proteínas. 
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Nas redes de interatómica 
geradas no STRING (Figura 
7), as linhas que unem as 
proteínas podem ser alteradas 
de acordo com vários 
parâmetros: 
 Confiança - as linhas 
que traduzam interacções de 
maior confiança surgem mais 
espessas que as de menor 
grau de confiança, 
 Evidência - existe mais 
que uma linha para cada 
interacção, cada cor das linhas corresponde a uma fonte de 
informação, 
 Acção - cada cor de cada linha é um tipo de acção entre as duas 
proteínas. 
 
O STRING disponibiliza funcionalidades que facilitam a interpretação dos 
dados de interatómica. 
É possível evidenciar grupos de proteínas de acordo com ontologias tais 
como: função molecular, processo biológico, componente celular e via de 
sinalização. Outra funcionalidade disponível consiste no clustering que 
agrupa as proteínas de acordo  com o seu STRING global score, ou seja, 
proteínas cujas interacções aparentam ser mais fidedignas. Os clusters ou 
grupos de proteínas podem ser modelados através de dois algoritmos, 
KMEANS e MCL, sendo que foi utilizado o algoritmo MCL que agrupa as 
interacções por "inflação" um parâmetro relativo à precisão do clustering. 
 
 
 
Figura 7 - Rede interatómica gerada no STRING, as 
diferentes cores das linhas representam as diferentes 
fontes de informação 
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3.2.4 Comparação entre os Oralomas da Diabetes Melitos tipo 1 e 2 e o 
total de anotações do Oralome 
 
 Após recolha dos dados referentes às 3 principais ontologias, funções 
moleculares, processos biológicos e vias de sinalização, é importante 
compará-los ao total de proteínas anotadas no Oralome. 
 Esta comparação permite determinar, com um intervalo de confiança 
específico,  os valores obtidos com valores expectáveis se se verificasse uma 
proporção directa relativamente ao total de proteínas anotadas no Oralome e 
entre os dois tipos de Diabetes Melitos entre si. Esta comparação foi 
efectuada de igual forma tanto para a Diabetes Melitos tipo 1 como para a 
Diabetes Melitos tipo 2. 
 
 Para esta comparação anotaram-se os valores obtidos no PANTHER 
de cada item de cada ontologia em Microsoft Excel. Para cada um destes 
colocou-se o valor do total de anotações do Oralome e do verificado na 
DMT1 e na DMT2 lado a lado. Por cálculo de proporção directa, foi inferido o 
valor que seria de esperar para cada item se houvesse proporção directa 
entre as entidades comparadas. 
 Para quantificar a diferença entre os valores observados e os valores 
esperados para cada item, calculou-se a diferença fraccional que consiste 
em: 
 
Em que       representa o valor observado ,   o valor esperado e DF a 
diferença fraccional. 
 A diferença fraccional é, então, o valor cuja multiplicação pelo 
valor esperado traduz quanto deveria ser adicionado ou subtraído ao valor 
observado para igualar o valor teoricamente esperado. 
 Recorrendo a uma distribuição binomial para calcular a probabilidade 
de se observar um resultado tão extremo que contradiga o que se inferiu, 
calculou-se o p-value. 
DF 
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 Quanto menor o p-value menor probabilidade do resultado 
apresentado ser devido à aleatoridade. Consequentemente um resultado é 
tanto mais significativo quanto menor for o seu p-value. 
 
3.2.5 Comparação da microflora oral da Diabetes Melitos tipo 1 e 2 
 
 Para comparar os microrganismos presentes na cavidade oral de 
pacientes com DMT1 e DMT2, começou-se por efectuar uma revisão 
bibliográfica de estudos de microbiologia oral. 
 Utilizou-se o repositório online de artigos científicos PubMed no dia 
29/6/2013 com a seguinte fórmula de pesquisa:  
 ((Micro*)OR(bacteria)) AND ((Oral) OR (saliv*)) AND ((type 1 diabetes 
mellitus) OR (DMT1)) - para a DMT1, obtendo 64 resultados; 
 ((Micro*)OR(bacteria)) AND ((Oral) OR (saliv*)) AND ((type 2 diabetes 
mellitus) OR (DMT2))- para a DMT2, obtendo 186 resultados. 
 
A informação seleccionada foi anotada em Microsof Excel 14.0 cujas colunas 
correspondem a entradas de formulário para preenchimento conforme a 
informação obtida. As colunas agruparam a informação por: 
 NCBI Taxon ID 
 Organism Name 
 All Body subsites 
 Regulation  
 Citation (NCBI ID) 
 Obs. 
 
 
25 
 
4 Resultados e Discussão 
Da aplicação das metodologias descritas na secção Material e Métodos, 
obtiveram-se os resultados que apresentamos e discutimos nesta secção. 
 
4.1 Revisão de literatura e anotação manual dos dados obtidos 
 
 A atualização do Oraloma da diabetes (secção 3.1) resultou na 
anotação de 29 novas proteínas no oraloma da Diabetes Melitos tipo 123–34 e 
58 novas proteínas no oraloma da Diabetes Melitos tipo 217,23,35,37,38,46,47,55 
(Anexos - Tabela 1 e 2); estes valores não coincidem com os valores 
analisados na caracterização segundo ontologias uma vez que de todas as 
proteínas anotadas no oraloma do paciente diabético existem certas 
proteínas que ainda não constam na base de dados do PANTHER. 
 Enquanto na Diabetes Melitos tipo 1 todos os estudos referidos 
utilizaram métodos de análise de amostras diferentes, na Diabetes Melitos 
tipo 2, 3 estudos quantificaram as proteínas com recurso ao teste bioquímico 
ELISA. Esta realidade evidencia a necessidade da elaboração de 
metodologias estandardizadas no que concerce a análise de saliva e tecidos 
orais de modo a não prejudicar a validade dos dados obtidos quando 
relacionados entre estudos. 
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Tabela 1 - Proteínas que os oralomas dos dois tipos de Diabetes Melitos têm em comum 
Cód. UniprotKB/Nome da 
proteína 
Diabetes 
Melitos tipo 1 
Diabetes 
Melitos tipo 2 
P01133 Pro-epidermal growth 
factor 
-1,2607 1,21 
P07686 Beta-hexosaminidase 
subunit beta 
-1,125 (non-
smokers) 
3,0 (smokers) 
não quantificado 
P04745 alpha-amylase 3,1407 4,02 
O00300 Tumor necrosis factor 
receptor superfamily member 
11B  
-2,5691 + 
P05231 Interleukin-6 29,1667 0,00 
P08246 Neutrophil elastase 1,0635 Não quantificado 
P01036 Cystatin-S Não quantificado -2,44 
P01037 Cystatin-SN Não quantificado -4,27 
P02808  Statherin 
diphosphorylated 
-3,11 Não quantificado 
P02810 Salivary acidic proline-
rich phosphoprotein  
-2,21 
 
Não quantificado 
P06702 Protein S100-A9 1,56 + 
 
 Na tabela 1 é possível verificar que apesar dos dois tipos de Diabetes 
Melitos possuírem proteínas em comum, estas podem apresentar regulações 
diferentes. O facto de possuírem regulações díspares pode consistir per se 
numa diferença, contudo é necessário ter em conta que existem outras 
variáveis que influenciaram estes valores, os estudos não seguem uma 
metodologia de colheita e análise comum dado não existir qualquer 
estandardização metodológica para a colheita e análise de amostras de 
tecidos e fluídos da cavidade oral. 
 
4.1.1 OralOma da Diabetes Melitos tipo 1 
 
 Antes do presente estudo haviam sido anotadas no Oralome 14 
proteínas, a revisão de literatura efectuada possibilitou o registo de mais 19 
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proteínas (em 22 anotações), perfazendo um total de 29 proteínas anotadas. 
Deste conjunto de proteínas, 21 provêm da saliva total, 8 de amostras da 
mucosa, 3 de amostras da glândula parótida e 1 oriunda do fluído crevicular 
(figura 8).  
 
Figura 8 - Proveniência histológica das proteínas alteradas em casos de Diabetes Melitos tipo 1 
4.1.2  OralOma da Diabetes Melitos tipo 2 
 Foram adicionadas 58 proteínas ao oraloma do paciente com Diabetes 
Melitos tipo 2 que antes deste estudo já contava com 445 proteínas anotadas 
no Oralome. O universo de proteínas do oraloma da Diabetes Melitos tipo 2 é 
composto por 493 proteínas oriundas de amostras de saliva, 6 proteínas são 
provenientes de amostras da glândula parótida e 4 das glândulas 
submandibulares/sublinguais (figura 9). 
 
Figura 9 - proveniência das proteínas alteradas em casos de Diabetes Melitos tipo 2 
 
 A maioria das proteínas anotadas provêm de estudos de proteómica 
que utilizaram a saliva como amostra. A saliva acaba por conter proteínas 
originárias de diversos tecidos e fluídos uma vez que contacta com todas as 
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estruturas orais e possui o contributo do fluído crevicular que sofre, por sua 
vez, influência directa do sangue por intermédio dos exsudados da 
microcirculação do sulco gengival conferindo à saliva capacidade de 
reproduzir doenças sistémicas e não apenas da cavidade oral. 
4.1.3 Metodologia dos estudos seleccionados na revisão da literatura 
 
 Das 33 anotações referentes à Diabetes Melitos tipo 1, 14 são 
resultado de estudos efectuados em crianças (sem especificar um intervalo 
de idades), 4 anotações provêm de estudos efectuados em indivíduos entre 
os 40 e os 58 anos de idade; o artigo que quantificou os níveis de elastase 
compreendeu indivíduos entre os 26 e os 51 anos; os estudos dos quais 
resultaram as restantes anotações envolveram indivíduos com idade inferior 
a 20 anos. A faixa etária tendencialmente mais jovem dos indivíduos 
estudados por cada autor justifica-se dado o onset da Diabetes Melitos tipo 1 
ocorrer nessas mesmas idades.  
 No que concerne a regulação das proteínas anotadas em casos de 
Diabetes 1, verificam-se, no caso da hexosaminidase (subunidade A e B) e 
da Beta-Galactosidase valores de regulação diferentes sejam os indivíduos 
estudados fumadores ou não26. A regulação que registou o valor mais 
elevado foi referente à Interleucina-8 (regulação: 35)27 seguida da 
Interleucina-6 (regulação: 29)27; a anotação com o valor mais baixo em 
termos de regulação pertence à Histatina-1 (Regulação: -3,14738)15. 
 À excepção de um estudo que compreendeu indivíduos com Diabetes 
Melitos tipo 2 dos 18 aos 66 anos, todos os estudos que quantificaram as 
proteínas alteradas em casos de Diabetes Melitos tipo 2 utilizaram 
populações de indivíduos com idades não inferiores a 30 anos. Este facto 
corrobora a informação que estabelece que o onset  e diagnóstico da 
Diabetes Melitos tipo 2 ocorre geralmente na idade adulta. 
 A proteína Elongation factor G, mitochondrial (Q6CRY5, regulação: 
702,46)55 foi a proteína com a regulação mais elevada, ao passo que a 
proteína FAM92A1 registou o valor mais baixo de regulação (regulação: -
91,53)55. 
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 Outro dos obstáculos à obtenção, por meio de estudo in silico, de 
dados estatísticos com significância, é a quantidade de proteínas anotadas 
em Diabetes Melitos tipo 1 (33 proteínas) ser diminuto quando comparado ao 
Oralome total (4376 proteínas) e mesmo ao Oraloma de Diabetes Melitos tipo 
2 que compreende 503 anotações. Urge, pois, desenvolver mais estudos de 
proteómica no sentido de identificar as proteínas orais alteradas em DMT1 
relativamente a indivíduos saudáveis. 
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4.2 Caracterização do Oraloma do paciente diabético 
4.2.1 Caracterização segundo Ontologias génicas 
 
 Por forma a analisar que funções moleculares possuem, em que 
processos biológicos intervêm e que vias de sinalização afectam, as 
proteínas alteradas em ambos os tipos de Diabetes foram caracterizadas de 
acordo com ontologias génicas. As ontologias génicas não irão ser traduzidas 
ao longo do presente trabalho de modo a evitar deturpar o seu significado 
biológico.  
 Para melhor comparar os dois tipos de Diabetes Melitos, recorreu-se a 
um cálculo de diferença fraccional, tendo por base a Diabetes Melitos tipo 2 
dado esta possuir um maior número de proteínas anotadas. Este cálculo 
traduz  a diferença entre quantas proteínas do Oraloma da Diabetes Melitos 
tipo 1 seriam expectáveis e as que foram anotadas na realidade em cada 
categoria ontológica, caso exista proporcionalidade directa entre a Diabetes 
Melitos tipo 1. Com recurso a uma distribuição binomial foi calculado o p-
value em cada diferença fraccional de modo a poder atribuir um grau de 
significância estatística a cada resultado (Anexo 3) 
4.2.1.1 Funções Moleculares  
Os oralomas dos dois tipos de Diabetes Melitos apresentam 4 tipos de 
funções moleculares comuns (Figura 10). 
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Figura 10 - Diferença fraccional do oraloma da DMT1 em relação ao oraloma da DMT2, estão 
apenas representadas as funções moleculares comuns entre os dois oralomas (* valores com p-
value<0,05) 
 A função molecular binding é uma função vasta, que pode englobar 
proteínas que com alguma probabilidade não se enquadram apenas nesta 
função molecular. Contudo, analisando as suas sub-funções, é possível 
denotar diferenças entre as proteínas implicadas na função de binding entre 
os dois oralomas (Figura 11). As 15 proteínas envolvidas em binding  no 
oraloma da diabetes Melitos tipo 1 são essencialmente citocinas e proteínas 
envolvidas na ligação a cálcio, ao passo que a função molecular de binding  
compreende 125 proteínas do oraloma da Diabetes Melitos tipo 2 que 
consistem não só em citocinas como também em proteínas de sinalização 
intracelular. No entanto, tendo em conta a redundância desta função 
molecular e não obstante o p-value da sua diferença fraccional entre os 
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oralomas dos dois tipos de Diabetes Melitos ser inferior a 0,05, esta é pouco 
informativa como parâmetro comparativo entre estas patologias. 
 
  
 
 
 
 
 
 
 
 
 
 Quanto à função molecular de catalytic activity no oraloma de Diabetes 
Melitos tipo 1 apenas é representada por 3 proteínas enquanto que no 
oraloma da Diabetes Melitos tipo 2 é desempenhada por 159 proteínas.  
 Outra função molecular comum entre os oralomas dos dois tipos de 
Diabetes Melitos é a de enzyme regulator activity. A DMT1 apresenta mais 
proteínas envolvidas nesta função molecular do que seria de esperar caso 
houvesse proporção à DMT2, isso traduz-se numa diferença fraccional de 
7,96. A função molecular de enzime regulator activity nos oralomas dos dois 
tipos de Diabetes Melitos consiste em funções de fosforilação de substratos 
por transferência de grupos fosfato a partir de ATP e noutras funções que 
advêm da gluconeogénese ou glicogenólise7. 
 À semelhança do verificado na função de enzyme regulator activity, 
existem igualmente mais proteínas no oraloma de Diabetes Melitos tipo 1 a 
desempenhar a função de receptor activity do que seria expectável caso se 
verificasse proporcionalidade entre os oralomas dos dois tipos de Diabetes 
Melitos. No oraloma de Diabetes Melitos tipo 1 existem 3 proteínas a 
Figura 11 - Funções moleculares contidas na função molecular de binding dos oralomas dos dois tipos de 
Diabetes Melitos (gráfico adaptado de http://www.pantherdb.com). 
DMT 1 DMT2 
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desempenhar esta função molecular, uma moduladora de receptor de 
factores de necrose tumoral, um factor de necrose tumoral e um factor de 
crescimento epidermal; no oraloma de Diabetes Melitos tipo 2 são 30 as 
proteínas que desempenham esta função as quais compreendem processos 
de regulação de receptores, processos imunológicos e de regulação da 
cascata complemento.   
 Todas as funções moleculares desempenhadas pelo Oraloma da 
Diabetes Melitos tipo 1 também são efectuadas pelo oraloma da diabetes 
Melitos tipo 2 sendo que este possui outras funções moleculares tais como 
antioxidant activity, ion channel activity, structural molecule activity, 
transcription regulator activity, translator regulator activity e transporter 
activity.  
 Apesar das diferenças descritas para esta ontologia é preciso ter em 
conta o facto que em proporção o oraloma descrito para a Diabetes Melitos 
tipo 2 ser substancialmente maior do que o descrito para a Diabetes Melitos 
tipo 1. 
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4.2.1.2 Processos Biológicos 
 
 A ontologia referente aos processos biológicos classifica os oralomas 
dos dois tipos de Diabetes Mellitus quanto aos processos biológicos por eles 
influenciados sendo que consiste na ontologia que providencia mais pontos 
de comparação entre os oralomas dos dois tipos de Diabetes Mellitus. 
 O oraloma da DMT1 contém proteínas que participam em 10 
processos biológicos ao passo que o oraloma da DMT2 inclui proteínas que 
participam em 16 processos biológicos. 
 
 
Figura 12 - Diferença fraccional do oraloma da DMT1 em relação ao oraloma da DMT2, estão 
apenas representadas os processos biológicos comuns entre os dois oralomas (* valores com 
p-value<0,05) 
 A ontologia referente aos processos biológicos classifica os oralomas 
dos dois tipos de Diabetes Mellitus quanto aos processos biológicos por eles 
influenciados sendo que consiste na ontologia que providencia mais pontos 
de comparação entre os oralomas dos dois tipos de Diabetes Mellitus. 
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 O oraloma da DMT1 contém proteínas que participam em 10 
processos biológicos ao passo que o oraloma da DMT2 inclui proteínas que 
participam em 16 processos biológicos. 
 Quando comparados, os dois oralomas influenciam 10 processos 
biológicos em comum, ou seja, todos os processos influenciados pelo 
oraloma da DMT1 são igualmente influenciados pelo oraloma da DMT2 
(Figura 12). Contudo, a comparação entre os processos biológicos 
influenciados é estatisticamente significativa, ou seja, apresenta um p-value 
inferior a 0,05 em apenas 3 processos biológicos.  
 Todos os processos biológicos possíveis de comparar entre os dois 
oralomas demonstraram que, face ao valor esperado tomando o oraloma da 
DMT2 como referência e partindo do princípio que existe proporcionalidade 
entre eles, o oraloma da DMT1 apresenta mais proteínas a influenciar cada 
processo biológico. 
    O processo biológico de cell communication apresenta uma 
diferença fraccional de 11,61 e p-value inferior a 0,05. Este processo 
biológico é principalmente influenciado pelas citocinas do oraloma da DMT1 
que influenciam, entre outros, dois sub-processos biológicos como a 
intracellular signaling cascade, que por sua vez compreende a JAK-STAT 
cascade e calcium-mediated signaling, e a cascata de sinalização JNK 
pertencente à sinalização por MAP-cinases que é um agonista da 
apoptose56,57. Os níveis elevados de glicose culminam na produção de 
espécies de oxigénio reactivas que activam a cascata de sinalização JAK-
STAT; esta via de sinalização induz a produção de Tumor Growth Factor-beta 
e de proteína da matriz extra-celular como a fibronectin e collagen IV58. As 
proteínas JAK são activadoras dos receptores membranares de citocinas e, 
na presença do ligando, são fosforiladas, desencadeando as STAT's que por 
sua vez aumentarão a transcrição de certas sequências de ADN que 
influenciarão a apoptose, proliferação e crescimento celular. O oraloma da 
DMT2 influencia este processo biológico também por influenciar, entre outras 
cascatas de sinalização, a cascata de sinalização JAK-STAT e MAPKKK58,59. 
  O processo biológico cellular process abrange os processos do ciclo 
de vida celular como a mitose, motilidade, adesão, citocinese e a acima 
referida comunicação celular. Por abranger este último processo, a 
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comunicação celular, que por si também se encontra aumentado no oraloma 
da DMT1 face ao oraloma da DMT2, é plausível que o processo biológico 
cellular process apresente também uma diferença fraccional positiva de 8,08 
com p-value inferior a 0,05. Contudo este processo biológico é redundante 
dado abranger outros processos biológicos do mesmo nível como a cell 
communication, cell adhesion e cell cycle, e consequentemente não se 
apresenta como um bom parâmetro comparativo entre os oralomas da DMT1 
e DMT2. 
 O valor mais elevado de diferença fraccional entre os oralomas dos 
dois tipos de Diabetes Melitos corresponde ao processo biológico de 
apoptosis que apresenta uma diferença fraccional de 17,74. Este valor de 
diferença fracionnal é estatisticamente significativo uma vez que apresenta 
um p-value inferior a 0,05. É expectável que o processo biológico de 
apoptosis apresente tal diferença fraccional dado a DMT1 ter características 
autoimunes, indutoras de apoptose a células do organismo, maioritariamente 
às células β pancreáticas6,60. 
 Dos processos biológicos comparados, 7 comparações não 
apresentam significância estatística. Na base de tal facto é provável que 
esteja a reduzida dimensão do oraloma da DMT1.  
 Os processos biológicos immune system process e response to 
stimulus são maioritariamente representados pelas citocinas e factores de 
necrose tumoral dos oralomas dos dois tipos de Diabetes Melitos.  
4.2.1.2.1 Processos biológicos afectados exclusivamente pelo oraloma da 
DMT2  
 
 Todos os processos biológicos representados no oraloma da DMT1 
estão também representados no oraloma da DMT2. Por outro lado, o oraloma 
da DMT2 inclui proteínas envolvidas em 5 processos biológicos de forma 
exclusiva, nomeadamente os processos de localization, transport, system 
process, homeostatic process e generation of precursor metabolites and 
energy. Tal pode ser explicado pelo reduzido oraloma da DMT1, dado que os 
processos biológicos enumerados estarão, de acordo com a patofisiologia da 
Diabetes Melitos, alterados em ambos os tipos de Diabetes Melitos7.  
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4.2.1.3 Caracterização das vias de sinalização afectadas 
 
 Por último, os oralomas dos dois tipos de Diabetes Melitos foram 
comparados na ontologia de vias de sinalização (Figura 13). A este nível o 
oraloma da DMT1 abrange 21 vias de sinalização, ao passo que o oraloma 
da DMT2 compreende 62 vias de sinalização, entre os dois oralomas existem 
9 vias de sinalização em comum que, quando comparadas desta forma, 7 
apresentam um p-value inferior a 0,05. 
 
 
Figura 13 - Diferença fraccional entre os oralomas dos dois tipos de Diabetes Melitos quanto à 
ontologia de vias de sinalização (* valores com p-value<0,05) 
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 A via de sinalização Wnt signaling pathway pode subdividir-se em três 
tipos que regulam desde a transcrição génica, a forma da célula e os níveis 
de cálcio intracelulares. Não obstante, o factor de transcrição TCF7L2, 
componente desta via de sinalização, foi identificado como factor de risco 
para a Diabetes Melitos tipo 2, sendo que esta via de sinalização influencia o 
desenvolvimento do pâncreas endócrino e modula a secreção de insulina, a 
sobrevivência e a proliferação das células-β do pâncreas e a adipogénese61–
64, a diferença fraccional apresentada (40,22) pode sugerir uma sobre-
expressão das proteínas desta via por forma a colmatar a perda de células-β 
do pâncreas.  
 O interferão-gama é uma citocina pleiotrófica que desempenha 
funções cruciais ao nível da imunidade intracelular contra patógenos e 
tumores. Esta citocina é maioritariamente produzida  por células Natural Killer 
e Natural Killer T no domínio na imunidade inata, contudo esta molécula 
desempenha funções na imunidade adquirida sendo secretada por células 
Th1 CD4 e CD865. O interferão gama produz efeitos tanto por activação das 
cinases da cascata de sinalização JAK-STAT como por outras vias de 
sinalização, o balanço entre o efeitos desta citocina entre a via de sinalização 
dependente ou independente da STAT1 é que determina a resposta biológica 
ao interferão gama59. A sinalização mediada por interferão gama está, 
comparativamente ao oraloma da DMT2, consideravelmente aumentada no 
oraloma da DMT1, dado expectável uma vez tratar-se de uma doença auto-
imune e o interferão gamma ser uma citocina sobre-regulada neste tipo de 
doenças66. 
 Da mesma forma que a sinalização mediada por interferão a, mais 
abrangente, sinalização mediada por interleucinas é a via de sinalização mais 
aumentada no oraloma da DMT1 face ao oraloma da DMT2.  
 Atendendo ao facto destas vias de sinalização posuírem proteínas em 
comum entre si, representaram-se num mapa de interatómica como na figura 
14. 
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 A Interleukin-6 é uma citocina com variadas implicações fisiológicas 
entre as quais a resistência à insulina, derivado dos seus efeitos inibitórios na 
transcrição génica de IRS-1 e GLUT-4, receptores de insulina67. 
Consequentemente, é crucial referir que no oraloma da DMT2 o único estudo 
que quantificou a expressão de Interleukin-6 registou uma regulação de 017, 
ao passo que o estudo que quantificou a interleukin-6 no oraloma da DMT1 
registou uma variação de 29,1727. A literatura actual não é consensual quanto 
à IL-6, havendo autores que quantificaram a IL-6 sérica como normal ou 
diminuída68,69, embora hajam outros autores a quantificar a mesma como 
aumentada e relacionada com a prévia hiperglicemia e a progressão de 
complicações microvasculares diabéticas70,71.  
 A via de sinalização da apoptose é influenciada apenas pelo Tumour 
Necrosis Factor-alpha no oraloma da DMT1 e por 3 proteínas (Cathepsin G, 
MAPK1 e uma subunidade da Hsp70). Apesar de ser uma comparação com 
p-value inferior a 0,05 a reduzida quantidade de proteínas nos oralomas dos 
DMT2 DMT1 
 Conjunto delimitado por           - Inflammation mediated by chemokine and cytokine signaling pathway 
Conjunto delimitado por           - Interleukin signaling pathway 
Figura 14 - Rede interatómica das proteínas envolvidas nas vias de sinalização de Inflammation mediated by 
chemokine and cytokine signaling pathway e interleukin signaling pathway, nos oralomas dos dois tipos de 
Diabetes Melitos. Rede determinada com recurso à ferramenta STRING. Confidence>0,7 
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dois tipos de Diabetes Melitos, não permite inferir nada não sendo um termo 
de comparação válido entre a DMT1 e DMT2 até haverem mais estudos de 
proteómica que quantifiquem mais proteínas nesta via de sinalização, o 
mesmo se aplica às vias de sinalização Heterotrimeric G-protein signaling 
pathway-Gi alpha and Gs alpha mediated pathway, endothelin signaling 
pathway, alzheimer disease-presenilin pathway e à Gonadotropin releasing 
hormone receptor pathway, embora esta última com p-value superior a 0,05.
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4.2.2 Comparação do oraloma do paciente diabético com o total de 
anotações do Oralome 
 
 Neste estudo comparativo, interessa relacionar o observado, ou seja, 
as proteínas anotadas nos dois tipos de Diabetes Melitos com o total de 
anotações em pacientes saudáveis (oraloma normal). Para tal foi utilizado 
uma vez mais o cálculo de diferença fraccional (Anexo 4 e 5). 
 
4.2.2.1 Processos Biológicos 
 
 Do estudo comparativo da ontologia génica de processos biológicos, 
verifica-se que apenas 3 resultados em 9 no oraloma da DMT1 e 4 resultados 
em 16 no oraloma da DMT2 apresentam significância estatística (Fig. 15).  
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 Do estudo comparativo da ontologia génica de processos biológicos, 
verifica-se que apenas 3 resultados em 9 no oraloma da DMT1 e 4 resultados 
em 16 no oraloma da DMT2 apresentam significância estatística (Fig. 15).  
 Considerando apenas os processos biológicos que apresentam p-
value inferior a 0,05, temos que os processos biológicos mais alterados no 
oraloma da DMT1 são os de cell communication, apoptosis e  immune 
system process; ao passo que no oraloma da DMT2 consistem nos 
processos biológicos de cell adhesion, immune system process, metabolic 
process e response to stimulus (este último sendo mais vago uma vez que 
engloba, entre outros, o já referido processo biológico de immune system 
process).  
 A comparação entre o total de proteínas anotados em indivíduos 
saudáveis e o oraloma dos dois tipos de Diabetes Melitos ao nível da 
ontologia de processos biológicos, permite concluir que os processos 
biológicos alterados que apresentam significância estatística corroboram 
certos aspectos da patofisiologia dos dois tipos de Diabetes Melitos e 
distinguem-nos das restantes patologias anotadas no Oralome. Alguns 
processos biológicos estão aumentados num dos tipos de Diabetes Melitos e 
diminuídos noutro, como é o caso dos processos biológicos: 
 Metabolic process, com uma diferença fraccional de 0,11 na DMT2 e   
-0,31 na DMT1 
 apoptosis, que apresenta uma diferença fraccional de 0,05 na DMT2 e 
1,9 na DMT1 
 cell communication, que regista uma diferença fraccional de 0,12 na 
DMT2 e 0,97 na DMT1 
considerando apenas os processos biológicos em que pelo menos uma das 
diferenças fraccionais apresenta p-value<0,05.  
 
4.2.2.2 Funções Moleculares 
 As funções moleculares desempenhadas pelas proteínas do oraloma 
dos dois tipos de Diabetes Melitos estão todas alteradas em relação ao total 
de proteínas anotadas em individuos saudáveis (oraloma normal) (Fig. 16). 
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Figura 16 - Diferença fraccional entre os oralomas dos dois tipos de Diabetes Melitos e o de 
indivíduos saudáveis, quanto à ontologia de funções moleculares (* valores com p-value<0,05) 
 As funções moleculares desempenhadas pelas proteínas do oraloma 
dos dois tipos de Diabetes Melitos estão todas alteradas em relação ao total 
de proteínas anotadas em individuos saudáveis (oraloma normal) (Fig. 16). 
 Ao nível da ontologia génica de funções moleculares, a comparação 
estatística entre o total de proteínas anotadas em individuos saudáveis e na 
DMT1, não é estatísticamente significativa dado a comparação de nenhuma 
das funções moleculares apresentar um p-value inferior a 0,05. Não obstante, 
é possível verificar que alguns destes valores reflectem aspectos já descritos, 
como a função molecular de catalytic activity. Esta encontra-se diminuída 
face ao estado de saúde, sendo constituída por serine proteases, a 
coagulação sanguínea dá-se por uma reacção em cadeia destas moléculas; 
seria, portanto, de esperar que esta função estivesse exacerbada em relação 
aos individuos saudáveis, mas por outro lado tem um p-value de 0,99. Como 
corolário, a comparação efectuada ao nível da ontologia génica de funções 
moleculares demonstra a reduzida dimensão do oraloma da DMT1, sendo os 
resultados a este nível mais aleatórios do que representativos dos padrões 
desta patologia. 
 A mesma análise estatística efectuada para o oraloma da DMT2 
regista 3 funções moleculares com p-values inferiores a 0,05, nomeadamente 
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as funções moleculares de antioxidant activity, catalytic activity e enzyme 
regulator activity. A função de antioxidant activity é a que está mais 
aumentada face ao total de proteínas anotadas em indivíduos saudáveis, 
justificando-se este valor atendendo ao elevado stress oxidativo em casos de 
Diabetes Melitos tipo 272.  
 Atendendo à patofisiologia da DMT2, que leva à ativação de vias 
enzimáticas alternativas e clivagem de moléculas que não a glicose para a 
obtenção de ATP's, é expectável que as funções moleculares de catalytic 
activity e enzyme regulator activity estejam exacerbadas face ao total de 
anotações do Oralome7. 
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4.2.2.3 Vias de Sinalização 
 
 A comparação estatística por diferença fraccional foi também 
efectuada para a ontologia de vias de sinalização. Devido aos dois tipos de 
Diabetes Melitos afectarem numerosas vias de sinalização, apenas foram 
representadas as que possuem um p-value inferior a 0,05 ( Fig. 17).  
 
 
Figura 17 - Diferença fraccional entre os oralomas dos dois tipos de Diabetes Melitos  e o de 
indivíduos saudáveis, quanto à ontologia de vias de sinalização (todos os valores apresentados 
possuem p-value<0,05) 
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 O oraloma da DMT1 compreende 23 vias de sinalização e quando 
comparadas com o oraloma normal, 21 destas vias de sinalização apresentou 
um p-value inferior a 0,05, o que confere significância estatística a estas 
comparações. A via de sinalização mais aumentada é a hedgehog signaling 
pathway e a Metabotropic glutamate receptor pathway. 
 No caso do oraloma da DMT2, que engloba 65 vias de sinalização, a 
comparação com o oraloma normal apenas apresenta significância estatística 
relativamente a 3 vias de sinalização. Uma dessas vias de sinalização é a de 
blood coagulation pathway que se apresenta aumentada face aos individuos 
saudáveis, como de resto seria de esperar. As outras duas vias de 
sinalização com p-value inferior a 0,05 consistem nas vias de parkinson 
disease e purine metabolism. 
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4.2.3 Caracterização da Interatómica das proteínas alteradas no oraloma de 
pacientes diabéticos 
 
 A interatómica, área que estuda as interações entre biomoléculas, 
neste caso proteínas, pode ser estudada com recurso à ferramenta 
bioinformática STRING. Os mapas de interatómica gerados permitem 
visualizar de forma mais directa as relações proteicas do oraloma da 
Diabetes Melitos tipo 1 e 2. 
 
  
 Na figura 18 está representada a rede interatómica das proteínas 
alteradas em casos de Diabetes Melitos tipo 1. No grupo A estão agrupadas 
as proteínas que não interagem com nenhuma outra ou o nível de confiança 
dessa interação encontra-se abaixo do valor estipulado como limite de 
Figura 18 - Rede interatómica das proteínas orais alteradas em casos de Diabetes Melitos tipo 1 (rede gerada 
com recurso à ferramenta STRING; Clustering: MCL; Confidence > 0,7) 
A
 
B
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confiança: 0,7. Nos restantes grupos de proteínas encontram-se as proteínas 
que interagem com uma confiança superior a 0,7. 
 O grupo B representa as interacções entre as citocinas, um processo 
fundamental devido à DMT1 ser uma doença autoimune. É possível verificar 
que as interações representadas favorecem os processos inflamatórios. 
 Nos estudos que quantificaram as subunidades A e B da beta-
hexosaminidase (HEXA e HEXB, respectivamente) verificou-se que a sua 
regulação era superior em indivíduos fumadores, o mesmo se constata em 
estudos de proteómica da urina excretada por pacientes diabéticos73; esta 
alteração, tendo em conta a interatómica que demonstra a reação da beta-
hexosaminidase e a beta-galactosidase (GLB1), pode inferir-se que existem 
efeitos na matriz extracelular provocados pela sobre-expressão desta 
proteína. 
 As proteínas histatin-1 e statherin (HST1 e STATH, respectivamente) 
encontram-se ambas sub-reguladas. A primeira (histatin-1)  é uma precursora 
da camada protectora proteica formada na superfície dentária e também 
exibe propriedades anti-fúngicas e anti-bacterianas39,40. Já a statherin 
estabiliza a saliva supersaturada com sais de cálcio, inibindo a sua 
precipitação. Esta proteína influencia também a formação dos cristais de 
hidroxiapatite na superfície dentária39,40. Estudos comprovam que a Diabetes 
Melitos afecta negativamente a expressão de proteínas salivares como as 
apresentadas39,39,45. Os níveis diminuídos de statherin podem mesmo estar 
relacionados com um aumento da prevalência de lesões da cavidade oral em 
pacientes diabéticos40. 
 As proteínas S100A8/9 formam um complexo denominado calprotectin 
e são proteínas pro-inflamatórias que desempenham papéis importantes na 
quimiotaxia74. Sendo uma doença autoimune, verifica-se que a regulação 
destas proteínas encontra-se aumentada no oraloma de pacientes com 
Diabetes Melitos tipo 1. 
 A via de sinalização da Proteína Cinase A (dependente de AMP 
cíclico) é referente à sinalização intracelular, promovendo os processos de 
gluconeogénese75. É, então, expectável que esta via de sinalização esteja 
exacerbada face à falta de glicose intracelular para produção de energia 
(ATP) nos casos de Diabetes Melitos tipo 1. Isto é confirmado pelos dados 
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disponíveis que mostram que estas duas subunidades, (PRKAR2A/B) estão 
sobre-reguladas (regulação:1,3532) no oraloma deste tipo de Diabetes, 
contudo mais uma vez se conclui que seria preciso dispor de mais proteínas 
anotadas que participassem nesta via de sinalização para poder afirmar que 
a mesma se encontra alterada positivamente. 
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 O oraloma da Diabetes Melitos tipo 2 é numeroso consistindo em 503 
proteínas, o que tem como consequência uma rede interatómica bastante 
complexa (Figura 19).  
 Na figura 19-A estão patentes parte das proteínas do sistema 
complemento, envolvido na coagulação sanguínea. Já na figura 19-B é 
representado o proteassoma, um complexo proteico responsável por 
degradar proteínas sinalizadas como dispensáveis por ubiquitinas.  
 
 
 
 52 
 
4.2.4 Comparação da microflora oral da Diabetes Melitos tipo 1 e 2 
 
 A cavidade oral é um ecossistema composto não só por tecidos e  
moléculas de origem humana como também pelas bactérias que nele se 
incluem, consequentemente existe uma reciprocidade de alterações no 
indivíduo e na microflora oral consoante as condições do meio, pH, 
temperatura, patologia do indivíduo, entre outros. Como corolário, a 
quantificação das diferentes espécies de microrganismos, pode ser 
característica de uma patologia que, alterando as condições orais do 
indivíduo, influi a prevalência e proliferação/diminuição de uma ou outra 
espécie microbiana. 
 Na Diabetes Melitos tipo 2 foram anotadas 146 entradas 
correspondentes a um total de 61 microrganismos dos domínios eucariota e 
bateriano provenientes de 16 artigos científicos76–91. Estes analisaram faixas 
etárias diferentes sendo que as idades estão compreendidas entre os 23 e os 
88 anos, não havendo distinção quanto ao género dos indivíduos. 72 
anotações correspondem a indivíduos não fumadores, 32 correspondem a 
fumadores e as restantes não possuem informações quanto aos hábitos 
sociais da população estudada.  
 Na Diabetes Melitos tipo 1 foram anotados 4 microrganismos a partir 
de 3 artigos científicos92–94 que não mencionavam hábitos sociais sendo que 
de todos nenhum utilizou indivíduos com mais de 18 anos. 
 Todos os microrganismos anotados na DMT1 estão também anotados 
na DMT2. Disto resulta que à luz da literatura actual apenas 4 espécies de 
microrganismos estão identificados como alterados na cavidade oral de 
ambos os tipos de Diabetes, nomeadamente: A. Actinomycetemcomitans, 
prevotella intermedia, Capnocytophaga spp., candida sp.. 
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Bolsas gengivais saudáveis  
aumentada aumentada diminuída 
Bolsas subgengivais com periodontite 
 aumentada diminuída 
Tabela 2 - Microrganismos comuns anotados que foram quantificados na cavidade oral de 
pacientes com ambos os tipos de Diabetes. (*Constant site - Face mesio-vestibular do primeiro 
molar superior direito; Deepest site - local mais profundo à sondagem) 
 54 
 
 A comparação do microbiota oral dos dois tipos de Diabetes Melitos 
encara diversos vieses que acabam por impossibilitar a inferência de factos 
prováveis. Nem todos os estudos que quantificam as mesmas bactérias em 
ambos os tipos de Diabetes o fazem de forma absoluta (indicando um valor 
específico para a concentração de certa estirpe bacteriana), os locais 
anatómicos de recolha da amostra não são os mesmos e a população 
estudada na Diabetes Melitos tipo 2 tem mais idade e certos hábitos, como 
fumar que não se verificam na população (na sua maioria) adolescente 
estudada na Diabetes Melitos tipo 1.  
 Conhecer o proteoma dos microrganismos característicos dos dois 
tipos de Diabetes Melitos e a interacção de tais proteínas com as proteínas 
do hospedeiro pode clarificar aspectos importantes destas patologias, 
nomeadamente a sua etiologia e os seus efeitos na cavidade oral. O grupo 
de investigação do Instituto de Ciências da Saúde da Universidade Católica 
Portuguesa - Centro Regional das Beiras está no presente a desenvolver 
uma ferramenta que permitirá efectuar esta análise. 
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5 Conclusão 
 
 A primeira conclusão possível após elaboração deste estudo é a 
necessidade de mais estudos de proteómica oral em pacientes com Diabetes 
Melitos tipo 1. Esta patologia conta com um reduzido número de proteínas 
anotadas comparativamente à Diabetes Melitos tipo 2. Deste facto advém 
que as possíveis inferências a retirar de uma comparação entre os oralomas 
dos dois tipos de Diabetes Melitos estão limitados pela dimensão dos 
mesmos. 
 É igualmente necessário estandardizar os métodos de colheita e 
análise em estudos de proteómica da cavidade oral, tendo em vista uma 
maior proporcionalidade entre os valores obtidos pelos diversos estudos, 
eliminando desta forma vieses. 
 Molecularmente, após a análise destas duas entidades patológicas, a 
Diabetes Melitos tipo 1 e tipo 2, conclui-se que tanto diferenças como 
semelhanças se refletem no conteúdo proteíco da cavidade oral. A 
dificuldade em estabelecer diferenças moleculares entre os dois tipos de 
Diabetes Melitos prende-se com o facto de no caso da Diabetes Melitos tipo 2 
esta só ser diagnosticada tardiamente quando as complicações decorrentes 
da Diabetes crónica estão já instaladas e os estudos de Diabetes Melitos tipo 
1 estudarem indivíduos com uma média de idades inferior a 20 anos perto do 
onset da doença. 
 Uma das principais conclusões deste estudo é que existem duas fases 
na Diabetes Melitos tipo 2 que afectam os dados de proteómica gerados. 
Uma primeira fase em que se dá o onset da patologia e uma segunda fase 
em que os efeitos no oraloma se devem ao estado hiperglicémico crónico e à 
acumulação de AGE's, sendo esta segunda fase um elemento de 
semelhança em relação à Diabetes Melitos tipo 1. 
 Actualmente, à luz dos dados disponíveis, verifica-se que no oraloma 
da Diabetes Melitos tipo 1 são mais abundantes proteínas com funções 
imunológicas e de sinalização celular, ao passo que no oraloma da Diabetes 
Melitos tipo 2 verifica-se uma maior concentração de proteínas catalíticas. 
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 Após este estudo comparativo é possível afirmar que a saliva reflecte, 
pelo menos, parcialmente as implicações sistémicas da patofisiologia da 
Diabetes Melitos tipo 1 e 2, como é reflectido pela comparação ao oraloma 
normal em que, por exemplo, os processos biológicos de immune system 
process se mostraram aumentados.  
 Entre as duas doenças, o cálculo de diferença fraccional mostrou 
sempre que os parâmetros ontológicos da DMT1 se encontram aumentados 
face aos da DMT2, o que pode ser atribuido à diferença de dimensão entre 
os dois oralomas. 
 O presente trabalho científico contribuiu para a actualização da base 
de dados do Oralome, interpretando a informação obtida com ferramentas 
bioinformáticas e cálculo de diferença fraccional. Culminou na constatação de 
que certas proteínas séricas caracteristicamente alteradas nos dois tipos de 
Diabetes Melitos estão também alteradas na saliva podendo esta ser utilizada 
como fluído de diagnóstico quando mais informação estiver disponível neste 
campo.  
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7 Anexos 
7.1 Anexo 1 - Tabela do oraloma da DMT1 
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7.2 Anexo 2 - Tabela do oraloma da DMT2 
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7.3 Anexo 3 - Comparação DMT1-DMT2 
 
Biological Process DMT2 
DMT1 
esperado 
DMT1 
observado 
Diferença 
fracional  P value 
cell communication  85 1,031 13 11,61 0,002462245 
cellular process  118 1,431 13 8,08 0,040874835 
apoptosis  22 0,267 5 17,74 0,016482194 
reproduction  12 0,146 1 5,87 0,569442458 
developmental process  52 0,631 3 3,76 0,715785571 
metabolic process  221 2,680 11 3,10 0,96307574 
cell cycle  33 0,400 3 6,50 0,402741419 
immune system process  105 1,274 11 7,64 0,086762533 
cell adhesion  37 0,449 1 1,23 0,931509418 
response to stimulus 72 0,873 8 8,16 0,111240069 
Total Oraloma normal  419 
    Total Diabetes 1 29 
     
Função Molecular DMT2 
DMT1 
esperado 
DMT1 
observado 
Diferença 
fracional p-value 
binding  146 1,770807194 15 7,47 0,045866893 
catalytic activity  182 2,207444584 3 0,36 0,999982504 
enzyme regulator activity  46 0,557925554 5 7,96 0,207615796 
receptor activity  35 0,424508574 3 6,07 0,440893433 
 
Pathway DMT2 
DMT1 
esperado 
DMT1 
observado 
Diferença 
fracional 
 
Alzheimer disease-presenilin pathway  4 0,05 2 40,22 0,03 
 
Apoptosis signaling pathway 
 
3 0,04 1 26,48 0,19 
Endothelin signaling pathway 2 0,02 2 81,45 0,01 
Gonadotropin releasing hormone receptor pathway  6 0,07 3 40,22 0,01 
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha 
mediated pathway 3 0,04 2 53,97 0,02 
Inflammation mediated by chemokine and cytokine signaling pathway  12 0,15 4 26,48 0,01 
Interleukin signaling pathway  2 0,02 3 122,67 0,00 
Interferon-gamma signaling pathway 1 0,01 1 81,45 0,07 
Wnt signaling pathway 2 0,02 1 40,22 0,13 
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7.4 Anexo 4 - DMT1 comparado ao OralOma normal 
 
Biological Process 
Oraloma 
Normal 
Diabetes 
esperado 
Diabetes 
observado 
Diferença 
fracional  P value 
cell communication  544 6,598 13 0,97 0,007013492 
cellular process  912 11,061 13 0,18 0,287905016 
apoptosis  142 1,722 5 1,90 0,026555207 
reproduction  109 1,322 1 -0,24 0,741568258 
developmental process  469 5,688 3 -0,47 0,942642667 
metabolic process  1307 15,852 11 -0,31 0,977046763 
cell cycle  269 3,263 3 -0,08 0,648398234 
immune system process  459 5,567 11 0,98 0,01466063 
cell adhesion  219 2,656 1 -0,62 0,938322452 
Total Oraloma normal  2391 
    Total Diabetes 1 29 
     
Função Molecular 
Oraloma 
Normal 
Diabetes 
esperado 
Diabetes 
observado 
Diferença 
fracional 
 binding  965 11,70 15 0,28 0,15 
catalytic activity  946 11,47 3 -0,74 1,00 
enzyme regulator 
activity  202 2,45 5 1,04 0,09 
receptor activity  188 2,28 3 0,32 0,40 
 
Pathway 
Oraloma 
Normal 
Diabetes 
esperado 
Diabetes 
observado 
Diferença 
fracional 
 
Alzheimer disease-presenilin pathway  23 0,28 2 6,17 0,03 
Apoptosis signaling pathway  23 0,28 1 2,58 0,24 
Beta1 adrenergic receptor signaling pathway  16 0,19 2 9,31 0,02 
Beta2 adrenergic receptor signaling pathway 16 0,19 2 9,31 0,02 
 
5HT1 type receptor mediated signaling pathway 
 
13 0,16 2 11,68 0,01 
Endothelin signaling pathway 17 0,21 2 8,70 0,02 
Enkephalin Release 13 0,16 2 11,68 0,01 
GABA-B receptor II signaling 10 0,12 2 15,49 0,01 
Hedgehog signaling pathway 3 0,04 2 53,97 0,00 
 
2391 29,00 
  
#NUM! 
 
29 0,35 
  
#NUM! 
Gonadotropin releasing hormone receptor pathway  58 0,70 3 3,26 0,03 
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway  29 0,35 2 4,69 0,05 
Inflammation mediated by chemokine and cytokine signaling pathway  74 0,90 4 3,46 0,01 
Interleukin signaling pathway  14 0,17 3 16,67 0,00 
Histamine H2 receptor mediated signaling pathway 9 0,11 2 17,32 0,01 
Interferon-gamma signaling pathway 4 0,05 1 19,61 0,05 
Metabotropic glutamate receptor group I pathway 3 0,04 2 53,97 0,00 
Metabotropic glutamate receptor group II pathway 16 0,19 2 9,31 0,02 
Metabotropic glutamate receptor group III pathway 12 0,15 2 12,74 0,01 
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Muscarinic acetylcholine receptor 2 and 4 signaling pathway 16 0,19 2 9,31 0,02 
Transcription regulation by bZIP transcription factor 4 0,05 2 40,22 0,00 
Wnt signaling pathway  43 0,52 1 0,92 0,41 
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7.5 Anexo 5 - DMT2 comparada ao oraloma normal 
 
 
Função Molecular 
Oralom
a 
Normal 
Diabetes 
esperad
o 
Diabetes 
observad
o 
Diferenç
a 
fracional 
 P 
value 
antioxidant activity  16 2,87 8 1,79 0,01 
binding  910 163,22 146 -0,11 0,96 
catalytic activity  909 163,04 182 0,12 0,03 
enzyme regulator activity  181 32,47 46 0,42 0,01 
ion channel activity  27 4,84 3 -0,38 0,86 
motor activity  30 5,38 2 -0,63 0,97 
receptor activity  167 29,95 35 0,17 0,19 
structural molecule activity  426 76,41 58 -0,24 0,99 
transcription regulator activity  86 15,43 3 -0,81 1,00 
translation regulator activity  45 8,07 4 -0,50 0,96 
transporter activity  149 26,73 26 -0,03 0,59 
      Total Oraloma normal  2336 
    Total Diabetes 419 
     
 
 
 
 
 
 
Biological Process 
Oraloma 
Normal 
Diabetes 
esperado 
Diabetes 
observado 
Diferença 
fracional 
 P 
value 
apoptosis  127 22,780 24 0,05 0,43 
cell adhesion  194 34,797 48 0,38 0,02 
cell communication  503 90,221 101 0,12 0,11 
cell cycle  237 42,510 39 -0,08 0,74 
cellular component organization  304 54,527 37 -0,32 1,00 
cellular process  843 151,206 141 -0,07 0,86 
developmental process  411 73,720 64 -0,13 0,91 
generation of precursor metabolites and 
energy  89 15,964 14 -0,12 0,73 
homeostatic process  30 5,381 5 -0,07 0,63 
immune system process  398 71,388 120 0,68 0,00 
localization  27 4,843 4 -0,17 0,71 
metabolic process  1261 226,181 250 0,11 0,01 
reproduction  68 12,197 14 0,15 0,34 
response to stimulus  286 51,299 84 0,64 0,00 
system process  281 50,402 49 -0,03 0,61 
transport  459 82,329 68 -0,17 0,97 
Total Oraloma normal  2336 
    Total Diabetes 419 
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Pathway 
Oraloma 
Normal 
Diabetes 
esperado 
Diabetes 
observado 
Diferença 
fracional 
 P 
value 
5-Hydroxytryptamine degredation  10 1,79 1,00 -0,44 0,83 
Adenine and hypoxanthine salvage pathway  3 0,54 2,00 2,72 0,10 
Alzheimer disease-amyloid secretase pathway  9 1,61 2,00 0,24 0,48 
Alzheimer disease-presenilin pathway  22 3,95 4,00 0,01 0,56 
Angiogenesis  28 5,02 3,00 -0,40 0,88 
Angiotensin II-stimulated signaling through G proteins and beta-arrestin  15 2,69 3,00 0,12 0,50 
Apoptosis signaling pathway  25 4,48 3,00 -0,33 0,83 
Asparagine and aspartate biosynthesis  2 0,36 2,00 4,58 0,05 
ATP synthesis  5 0,90 1,00 0,12 0,59 
Axon guidance mediated by netrin  7 1,26 2,00 0,59 0,36 
Axon guidance mediated by semaphorins  8 1,43 1,00 -0,30 0,76 
Axon guidance mediated by Slit/Robo  8 1,43 1,00 -0,30 0,76 
B cell activation  16 2,87 3,00 0,05 0,55 
Blood coagulation  16 2,87 10,00 2,48 0,00 
Cadherin signaling pathway  19 3,41 2,00 -0,41 0,86 
Cytoskeletal regulation by Rho GTPase  50 8,97 7,00 -0,22 0,79 
De novo purine biosynthesis  12 2,15 1,00 -0,54 0,88 
Dopamine receptor mediated signaling pathway  25 4,48 1,00 -0,78 0,99 
EGF receptor signaling pathway  35 6,28 8,00 0,27 0,29 
Endothelin signaling pathway  16 2,87 2,00 -0,30 0,78 
FAS signaling pathway  9 1,61 3,00 0,86 0,22 
FGF signaling pathway  31 5,56 9,00 0,62 0,11 
Fructose galactose metabolism  4 0,72 1,00 0,39 0,51 
Glutamine glutamate conversion  3 0,54 1,00 0,86 0,42 
Glycolysis  17 3,05 5,00 0,64 0,19 
Gonadotropin releasing hormone receptor pathway  55 9,87 6,00 -0,39 0,93 
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated 
pathway  27 4,84 3,00 -0,38 0,86 
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated 
pathway  21 3,77 2,00 -0,47 0,89 
Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction  10 1,79 1,00 -0,44 0,83 
Huntington disease  59 10,58 9,00 -0,15 0,73 
Inflammation mediated by chemokine and cytokine signaling pathway  74 13,27 12,00 -0,10 0,68 
Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade  9 1,61 1,00 -0,38 0,80 
Integrin signalling pathway  84 15,07 16,00 0,06 0,44 
Interferon-gamma signaling pathway  3 0,54 1,00 0,86 0,42 
Interleukin signaling pathway  13 2,33 2,00 -0,14 0,68 
N-acetylglucosamine metabolism  2 0,36 1,00 1,79 0,30 
Nicotine pharmacodynamics pathway  14 2,51 1,00 -0,60 0,92 
Nicotinic acetylcholine receptor signaling pathway  36 6,46 1,00 -0,85 1,00 
p38 MAPK pathway  9 1,61 2,00 0,24 0,48 
p53 pathway  15 2,69 1,00 -0,63 0,93 
Parkinson disease  36 6,46 18,00 1,79 0,00 
PDGF signaling pathway  18 3,23 1,00 -0,69 0,96 
Pentose phosphate pathway  5 0,90 2,00 1,23 0,23 
Phenylalanine biosynthesis  2 0,36 2,00 4,58 0,05 
PI3 kinase pathway  14 2,51 1,00 -0,60 0,92 
Plasminogen activating cascade  8 1,43 4,00 1,79 0,06 
Purine metabolism  1 0,18 2,00 10,15 0,01 
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Pyridoxal phosphate salvage pathway  1 0,18 1,00 4,58 0,16 
Pyrimidine Metabolism  6 1,08 1,00 -0,07 0,66 
Pyruvate metabolism  7 1,26 3,00 1,39 0,13 
Ras Pathway  20 3,59 3,00 -0,16 0,70 
Salvage pyrimidine deoxyribonucleotides  2 0,36 1,00 1,79 0,30 
Salvage pyrimidine ribonucleotides  6 1,08 2,00 0,86 0,29 
Synaptic_vesicle_trafficking  8 1,43 1,00 -0,30 0,76 
T cell activation  20 3,59 5,00 0,39 0,29 
TCA cycle  6 1,08 2,00 0,86 0,29 
TGF-beta signaling pathway  9 1,61 2,00 0,24 0,48 
Toll receptor signaling pathway  10 1,79 3,00 0,67 0,27 
Tyrosine biosynthesis  2 0,36 2,00 4,58 0,05 
Ubiquitin proteasome pathway  24 4,30 4,00 -0,07 0,62 
Vasopressin synthesis  5 0,90 2,00 1,23 0,23 
VEGF signaling pathway  12 2,15 2,00 -0,07 0,63 
Vitamin B6 metabolism  1 0,18 1,00 4,58 0,16 
Wnt signaling pathway  41 7,35 2,00 -0,73 0,99 
Xanthine and guanine salvage pathway  2 0,36 2,00 4,58 0,05 
      
Total Oraloma normal  2336 
    
Total Diabetes 419 
     
UniProtKBAC Name Parotid
Whole 
Saliva
Crevicular Fluid Mucosa Health
Disease 
(MeSH ID)
Regulation Age group Gender* Social Habits* Methods of Sampling** Methods of Analysis*** Type of Study
F6KPG5 Albumin
x x 68003922 -0,3 4-17 MF
otherwise healthy children, healthy children in the control 
group Protein-dye binding Cross-sectional
O00300
Tumor necrosis factor receptor 
superfamily member 11B 
(Osteoclastogenesis inhibitory factor) 
(Osteoprotegerin)
x x 68003922 -1,6 MF
non-smokers. healthy individuals with no medication which 
could influence periodontitis except for diabetes type 1 
medication, not pregnant womenwithout using any 
contraceptive treatment or lactant. All non-smoking 
individuals gingival tissue samples
RNA extraction and 
measured by 
biophotometer Proteomics
P01036
Cystatin-S (Cystatin-4) (Cystatin-SA-III) 
(Salivary acidic protein 1)
x x 68003922 Children
P01037
Cystatin-SN (Cystain-SA-I) (Cystatin-1) 
(Salivary cystatin-SA-1)
x x 68003922 Children
P01133
Pro-epidermal growth factor (EGF) 
[Cleaved into: Epidermal growth factor 
(Urogastrone)]
x x 68003922 -0,3 48,7 MF
periodontally healthy, excluded: patients under 
pharmacological treatment, hormonal contraception, 
pregnants.
Quantikine Human EGF 
Immunoassay
P01375 Tumor necrosis factor
x x 68003922 -0,4 MF
non-smokers. healthy individuals with no medication which 
could influence periodontitis except for diabetes type 1 
medication, not pregnant womenwithout using any 
contraceptive treatment or lactant. All non-smoking 
individuals gingival tissue samples
RNA extraction and 
measured by 
biophotometer Proteomics
P01579 Interferon gamma
x x 68003922 2,3 MF
non-smokers. healthy individuals with no medication which 
could influence periodontitis except for diabetes type 1 
medication, not pregnant womenwithout using any 
contraceptive treatment or lactant. All non-smoking 
individuals gingival tissue samples
RNA extraction and 
measured by 
biophotometer Proteomics
P01584
Interleukin-1 beta (IL-1 beta) 
(Catabolin)
x x 68003922 5 MF
non-smokers. healthy individuals with no medication which 
could influence periodontitis except for diabetes type 1 
medication, not pregnant womenwithout using any 
contraceptive treatment or lactant. All non-smoking 
individuals gingival tissue samples
RNA extraction and 
measured by 
biophotometer Proteomics
P01876 Ig alpha-1 chain C region
x x 68003922 -0,3 10-19 MF
orherwise Healthy
direct enzyme-linked 
immunosorbent assay non-Proteomics
P02808 Statherin x x 68003922 -2,1 Children
P02810
Salivary acidic proline-rich 
phosphoprotein 1/2 (Db-s) 
x x 68003922 -1,2 Children
P02814
Submaxillary gland androgen-
regulated protein 3B
x x 68003922 -1,3 Children
P04745 Alpha-amylase 1 x x 68003922 3,2 42-68 MF tissue samples Immunohistochemistry non-Proteomics
P05109 Protein S100-A8 x x 68003922 1,4 Children
P05231 Interleukin-6 
x x 68003922 29,2 MF
non-smokers. healthy individuals with no medication which 
could influence periodontitis except for diabetes type 1 
medication, not pregnant womenwithout using any 
contraceptive treatment or lactant. All non-smoking 
individuals gingival tissue samples
RNA extraction and 
measured by 
biophotometer Proteomics
P06702 Protein S100-A9 x x 68003922 1,6 Children
P06865 Beta-hexosaminidase subunit alpha
x x 68003922 1,3 20-35 MF
non-smokers
Chatteriee et al. Method 
(1975) Proteomics
P06865 Beta-hexosaminidase subunit alpha
x x 68003922 2,3 20-35 MF
Smokers. periodontally healthy, excluded: patients under 
pharmacological treatment, hormonal contraception, 
pregnants.
Chatteriee et al. Method 
(1975) Proteomics
P07686 Beta-hexosaminidase subunit beta 
x x 68003922 -0,12 20-35 MF
non-smokers. periodontally healthy, excluded: patients under 
pharmacological treatment, hormonal contraception, 
pregnants.
Chatteriee et al. Method 
(1975) Proteomics
P07686 Beta-hexosaminidase subunit beta 
x x 68003922 3 20-35 MF
smokers. periodontally healthy, excluded: patients under 
pharmacological treatment, hormonal contraception, 
pregnants.
Chatteriee et al. Method 
(1975) Proteomics
P08246 Neutrophil elastase
x x 68003922 1,1 26-51 MF
average was a smoker for 6,5+-3,2 yrs. dmt-1 patients for 
10,03+-5,73 yrs ELISA non-Proteomics
P09228 Cystatin-SA (Cystatin-2) x x 68003922 Children
P10145 Interleukin-8 (IL-8)
x x 68003922 35 MF
non-smokers. healthy individuals with no medication which 
could influence periodontitis except for diabetes type 1 
medication, not pregnant womenwithout using any 
contraceptive treatment or lactant. All non-smoking 
individuals gingival tissue samples
RNA extraction and 
measured by 
biophotometer Proteomics
P12838
Neutrophil defensin 4 (Defensin, alpha 
4) (HNP-4) (HP-4)
x x 68003922 1,9 Children
P13861
cAMP-dependent protein kinase type 
II-alpha regulatory subunit
x x 68003922 1,4 42-68 MF
tissue samples Immunohistochemistry non-Proteomics
P15515 Histatin-1 x x 68003922 -2,2 Children
P15516 Histatin-3 x x 68003922 -1,1 Children
P16278 Beta-galactosidase 
x x 68003922 -0,3 20-35 MF
non-smokers. periodontally healthy, excluded: patients under 
pharmacological treatment, hormonal contraception, 
pregnants.
Chatteriee et al. Method 
(1975) Proteomics
P16278 Beta-galactosidase
x x 68003922 -0,23 20-35 MF
smokers. periodontally healthy, excluded: patients under 
pharmacological treatment, hormonal contraception, 
pregnants.
Chatteriee et al. Method 
(1975) Proteomics
P18510
Interleukin-1 receptor antagonist 
protein (IL-1RN)
x x 68003922 1,7 MF
non-smokers. healthy individuals with no medication which 
could influence periodontitis except for diabetes type 1 
medication, not pregnant womenwithout using any 
contraceptive treatment or lactant. All non-smoking 
individuals gingival tissue samples
RNA extraction and 
measured by 
biophotometer Proteomics
P22301 Interleukin-10 (IL-10)
x x 68003922 -1,8 MF
non-smokers. healthy individuals with no medication which 
could influence periodontitis except for diabetes type 1 
medication, not pregnant womenwithout using any 
contraceptive treatment or lactant. All non-smoking 
individuals gingival tissue samples
RNA extraction and 
measured by 
biophotometer Proteomics
P31323
cAMP-dependent protein kinase type 
II-beta
x x 68003922 1,4 42-68 MF
tissue samples Immunohistochemistry non-Proteomics
P59665 Neutrophil defensin 1 x x 68003922 1,9 Children
P59666 Neutrophil defensin 3 x x 68003922 + Children
P62328 Thymosin beta-4 x x 68003922 Children
P63313 Thymosin beta-10 x x 68003922 Children
Q9Y298 IgG VH protein
x x 68003922 2,4 10-19 MF
otherwise Healthy
direct enzyme-linked 
immunosorbent assay non-Proteomics
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P62258
x x -2,3 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q04917
x x -3 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P61981
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P31947
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P63104
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P05387
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P52209
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O95336
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P11021
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P39687
x x 3,3 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P68133
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P61160
x x 3,4 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O15143
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O15144
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O15511
x x 6,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P61158
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07108
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P23526
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q01518
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q10588
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P43652
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P14550
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P30838
x x -2,2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O60218
x x -3,3 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q5STX8
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02763
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P01009
x x 3,2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04217
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
71
P02765
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P01023
x x 2,2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
A8K2U0
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P12814
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P06733
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P54802
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P01019
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04083
x x -3,6 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07355
x x -4,3 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P12429
x x -2,7 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P03973
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P01008
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q10567
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02647
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02652
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04114
x x -4,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P05090
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O95445
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P08519
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9ULZ3
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P05089
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P17174
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00505
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P06576
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O75882
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P20160
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q7M4Q5
x x 5,4 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02812
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02749
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
72
P61769
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07686
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O00462
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9NP55
x x 5,5 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q96DR5
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q8TDL5
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P80723
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q4LE82
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9BRF8
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q14CN2
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P27482
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9NZT1
x x -2,2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P27824
x x -7,7 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07384
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q59HE3
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q53G71
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00915
x x -4,4 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00918
x x -5,5 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P23280
x x 3,8 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q53H57
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P16870
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P31997
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04040
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P49913
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07858
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07339
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P08311
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07711
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P25774
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
73
Q9UBR2
x x -2,9 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6YHK3
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q1T7A3
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O43866
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P13987
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q8N274
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6ZW64
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P29373
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9Y3E8
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P36222
x x 2,7 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q15782
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O00299
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q13185
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O75390
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q00610
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P10909
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q14019
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P23528
x x 2,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02452
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P12109
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00736
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P06681
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P01031
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P13671
x x 4,8 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P10643
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07357
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07358
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07360
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02748
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
74
P00751
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P08603
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P05156
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O75367
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UBG3
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P31146
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P01040
x x -2,4 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P01034
x x 2,2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P28325
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P54108
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P32320
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04839
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P30046
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UGM3
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q02487
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q02413
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P32926
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P15924
x x -5,9 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P09417
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q01459
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P53634
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UHL4
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P27487
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P27695
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q4W4Y1
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q15075
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9BW34
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P19957
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P26641
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
75
P13639
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9NZ08
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P30040
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9BS26
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P14625
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q92817
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P12724
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P61916
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q96HE7
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q16610
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P15311
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P52907
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P47755
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q01469
x x -2,6 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q86UX7
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02671
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02751
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P23142
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O00602
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O75369
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P30043
x x -6,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P15328
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P09467
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04075
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q53XB4
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P16930
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P09958
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q08380
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q92820
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
76
P17900
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O95479
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P46926
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P14314
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00367
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P35754
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00390
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P78417
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P09211
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P48637
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04406
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P06737
x x 3,3 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P46976
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q92896
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q8NBJ4
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P28676
x x -7,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P28799
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6ICN0
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P34932
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04792
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07900
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P08238
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9Y5Z4
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q14103
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P31943
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q53F48
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P61978
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P22626
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q5U071
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
77
P04196
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q4VB24
x x 2,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04908
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6FI13
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q99877
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q8N1C8
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00492
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P11215
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P05107
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q8WWA0
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
A2RTY6
x x 3,2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P19827
x x 2,8 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q14624
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q12906
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07476
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P06870
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O43240
x x -5 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UBX7
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UKR3
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P01042
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q5TCI8
x x -3,3 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P20700
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q03252
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02750
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P30740
x x 2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P09960
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6FGL0
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00338
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07195
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
78
P51884
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O95274
x x -2,3 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q14210
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P42785
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P40121
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P40925
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P40926
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O75556
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P08582
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P16035
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UJ68
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P28482
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P26038
x x 2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P08571
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q8WXI7
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P98088
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P98088
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P24158
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P41218
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P60660
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P19105
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UL88
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P20933
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O95865
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O14745
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UJ70
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P15586
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q96PD5
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q53H01
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
79
Q5TD07
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q09666
x x 3,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P22894
x x 2,4 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P22894
x x + 35-65 M/F
Non-smoker, no 
intake of 
antibiotics in the 
last 6 months, no 
pregnancy or 
lactation
Non-stimulated whole expectorated saliva; Subjects refrained from eating, drinking, and oral hygiene. 
ELISA 20192865
P14598
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q15080
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P59666
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P08246
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P80188
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P43490
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P05204
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P10153
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UNZ2
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P80303
x x 2,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6UX06
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P26022
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O75594
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P19021
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q0VDC6
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P62937
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P23284
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O60664
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O60437
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q06830
x x -2,6 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P30044
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P30086
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P36871
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q96G03
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
80
P00558
x x -3,2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q53G35
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6P4A8
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P55058
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P36955
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P03952
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q5VY30
x x 2,2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00747
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P13797
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P43034
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q15149
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P21128
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P09668
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O43490
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P27918
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q14914
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q16651
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q06323
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P25786
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P25787
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P25789
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P28066
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P60900
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O14818
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q86U62
x x -6,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P20618
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P49721
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P49720
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P28062
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
81
P02760
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07237
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P30101
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q15084
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q99497
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q96BQ1
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9NUQ9
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q5T949
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P31949
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P80511
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P29034
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P26447
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P31151
x x -2,9 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P06702
x x + 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q70J99
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q08188
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P22735
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P22061
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00734
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07988
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00491
x x -2,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P55786
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O60361
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O00764
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P14618
x x 3,5 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P50395
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6FHR0
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P46940
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P51149
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
82
Q7Z3Y5
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9HD89
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q15300
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
A0N5G5
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
A0N5G3
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
A2J1M4
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
A2J1N6
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P52565
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P52566
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P13489
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07998
x x 3,8 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O00584
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02810
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9NQ38
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P29508
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q4VAX6
x x 2,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P27169
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q5VXV3
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O75368
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9H299
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P62316
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P35326
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q96RM1
x x -2,9 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UBC9
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q14515
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02549
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q13813
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q01082
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q59FP5
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
83
P02808
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O00391
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P00441
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04179
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6UWP8
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q99536
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O00560
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9Y490
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6FGD7
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9BRA2
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P30048
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q59E99
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6FGX5
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P37837
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P20061
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P61586
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P37802
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P55072
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q53EM5
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P13693
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q15631
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O60235
x x -2,1 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9UL52
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02766
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02766
x x 2,4 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q07654
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O14773
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q9NYL9
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
84
O00300
x x + 35-65 M/F
Non-smoker, no 
intake of 
antibiotics in the 
last 6 months, no 
pregnancy or 
lactation
Non-stimulated whole expectorated saliva; Subjects refrained from eating, drinking, and oral hygiene. 
ELISA 20192865
P09758
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P78324
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P68036
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P61088
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P22314
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q969H8
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q6P5S2
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P11684
x x 10,4 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q53F10
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q5NV91
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q5NV82
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O75436
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O95498
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P50552
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q12907
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P08670
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P18206
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P02774
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P04004
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q14508
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O75083
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P12956
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q96DA0
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P09871
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P23141
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q13126
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q16881
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
85
Q6XQN6
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
O43278
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P06753
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P07910
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P11413
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P25788
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P31946
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P54819
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P58499
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P60953
x x 4,8 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
P67936
x x -3,8 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q08209
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q12805
x x 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q13231
x x -2,2 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
Q14624
x x 2,6 36-62 M/F
Non-smoker; Non-
alcoholic; no 
pregnancy
Unstimulated saliva (20mL). Briefly, at 8 a.m. (before breakfast), the subjects were asked to rinse their mouths thoroughly with water, then to tilt 
their heads forward and allow saliva to flow into a sterile container for 5 min. These specimens were immediately frozen and stored at -80 °C until 
analysis.
Five saliva samples each from the control and DM groups were pooled separately and 
subjected to two-dimensional liquid chromatography (2-DLC) and LC-tandem mass 
spectrometry (LC-MS/MS) analysis 19118452
A1XBS5
x x -91,53 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
O95969
x x 17,47 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P01036
x x -2,44 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P01037
x x -4,27 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P01833
x x -6,63 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P01834
x x -1,58 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P01842
x x -1,52 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
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P01857
x x 1,52 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P01876
x x -5,40 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P02533
x x -5,77 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P0DJI8
x x -5,00 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P0DJI9
x x -5,00 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS)
N4,N4-
dimethylas
paragine Selected salivary biomarkers upregulated in type 2 diabetic patients22314925
P02768
x x 4,08 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P02787
x x -1,64 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS)
N-linked 
and O-
linked Selected salivary biomarkers upregulated in non-diabetic control patients22314925
P04745
x x 4,02 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS)
N-linked 
glycosylate
d Selected salivary biomarkers upregulated in non-diabetic control patients22314925
P05976
x x -2,41 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P08118
x x 16,91 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P12273
x x -1,72 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS)
N-linked 
glycosylate
d Selected salivary biomarkers upregulated in type 2 diabetic patients22314925
P19961
x x 2,27 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS)
N-linked 
glycosylate
d Selected salivary biomarkers upregulated in non-diabetic control patients22314925
P19961
x x 1,78 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) Selected salivary biomarkers upregulated in non-diabetic control patients22314925
P25311
x x -1,56 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
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P31025
x x -1,59 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P48723
x x 3,23 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P55042
x x -63,41 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q53EP0
x x -2,17 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q5F1R6
x x -9,81 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q8NGY0
x x -9,18 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q8TAX7
x x -4,43 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q99102
x x 13,17 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q9HC84
x x -2,16 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q9HC84
x x -1,82 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q9UIV8
x x 6,54 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q9Y5J9
x x 1,90 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q6CRY5
x x 702,46 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating,
and practicing any oral hygiene habits 2 hours before sample
collection. All sample collection was completed before lunch
(9 am–12 pm). B4 ml of unstimulated whole saliva sample was
collected and centrifuged. The supernatant was placed into
aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
Q92210
x x 4,32 55-75 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Patients were asked to refrain from drinking, eating, and practicing any oral hygiene habits 2 hours before sample collection. All sample collection 
was completed before lunch (9 am–12 pm). B4 ml of unstimulated whole saliva sample was collected and centrifuged. The supernatant was placed 
into aliquots of 250 ml and immediately frozen in liquid nitrogen.
d label-free diﬀerential protein expression analysis using multidimensional liquid 
chromatography/tandem mass spectrometry (2D-LC-MS/MS) 22314925
P10809
x x 4,25 18-66 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Other studies on HSPs have attempted to control for environmental stresses by asking patients to refrain from exertion, smoking, caffeine and 
alcohol for 2–24 h and not taking samples from subjects with active bacterial or viral infection or other illness. Similar restrictions were applied to 
our participants.
ELISA
21748374
88
P01133
x x 1,21Mean 48.7  (male, 50.7 years old; female, 47.5 years old)MF
Non-smoker; Non-
alc holic; no 
pregnancy
Patients were instructed to expectorate every 6 h into pre-labeled sterile collection tubes. Unstimulated whole resting saliva (approximately 3 ml) 
was obtained from each
patient by passive expectoration at 0, 6, 12, 18, 24, 30, 36 and 42 h. Patients were asked to collect approximately 3 ml of whole saliva without the 
assistance of chewing material. No time limit was enforced to collect the requested volume of material. Samples were stored at ÿ20°C until 
evaluated.
Quantikine Human EGF Immunoassay
10989322
P10645
x x 9,50 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Saliva samples were taken from ST patients each with or without diabetes type Q. All samples were taken without oral  salivary gland  stimulation. 
The patients were  instructed  to salivate directly into Falcon tubes (Falcon fT  ml, Germany) including fTTμl RL (QV,Qf,Qd) buff er with protease 
inhibitors (Complete cocktail tablets, Roche, 
Germany)  for  preserving  proteins  from  degradation processes. 
Electrophoresis 
biomarker  for  cancer (epithelial tumours)20192923
P01876 x
x 1,30 34-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
subjects were requested not to eat, drink or perform oral hygiene measures after midnight the night before saliva collections. Unstimulated whole 
(UW) saliva, stimulated
parotid (SP) and stimulated (SS) and unstimulated (US) submandibular/sublingual saliva were collected from each subject between 8:00 and 10:00 
a.m. SP saliva was collected using a modified Carlson-Crittenden cup (13) and US and SS saliva was collected with a micropipette connected to a 
mini-vacuum pump (14). Salivary stimulation was
achieved by swabbing the lateral surfaces of the tongue with 0.1 mol/L (2% w/v) citric acid every 30 s. The sequence and times of collection of 
saliva was as follows: UW (5 min); US (5 min); SP (5 min after 2 min to establish a flow); SS (3 min).
ELISA
11014514
P61626 x
x 1,26 34-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
subjects were requested not to eat, drink or perform oral hygiene measures after midnight the night before saliva collections. Unstimulated whole 
(UW) saliva, stimulated
parotid (SP) and stimulated (SS) and unstimulated (US) submandibular/sublingual saliva were collected from each subject between 8:00 and 10:00 
a.m. SP saliva was collected using a modified Carlson-Crittenden cup (13) and US and SS saliva was collected with a micropipette connected to a 
mini-vacuum pump (14). Salivary stimulation was
achieved by swabbing the lateral surfaces of the tongue with 0.1 mol/L (2% w/v) citric acid every 30 s. The sequence and times of collection of 
saliva was as follows: UW (5 min); US (5 min); SP (5 min after 2 min to establish a flow); SS (3 min).
ELISA
11014514
P02788 x
x 1,70 34-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
subjects were requested not to eat, drink or perform oral hygiene measures after midnight the night before saliva collections. Unstimulated whole 
(UW) saliva, stimulated
parotid (SP) and stimulated (SS) and unstimulated (US) submandibular/sublingual saliva were collected from each subject between 8:00 and 10:00 
a.m. SP saliva was collected using a modified Carlson-Crittenden cup (13) and US and SS saliva was collected with a micropipette connected to a 
mini-vacuum pump (14). Salivary stimulation was
achieved by swabbing the lateral surfaces of the tongue with 0.1 mol/L (2% w/v) citric acid every 30 s. The sequence and times of collection of 
saliva was as follows: UW (5 min); US (5 min); SP (5 min after 2 min to establish a flow); SS (3 min).
ELISA
11014514
P02768 x
x 1,25 34-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
subjects were requested not to eat, drink or perform oral hygiene measures after midnight the night before saliva collections. Unstimulated whole 
(UW) saliva, stimulated
parotid (SP) and stimulated (SS) and unstimulated (US) submandibular/sublingual saliva were collected from each subject between 8:00 and 10:00 
a.m. SP saliva was collected using a modified Carlson-Crittenden cup (13) and US and SS saliva was collected with a micropipette connected to a 
mini-vacuum pump (14). Salivary stimulation was
achieved by swabbing the lateral surfaces of the tongue with 0.1 mol/L (2% w/v) citric acid every 30 s. The sequence and times of collection of 
saliva was as follows: UW (5 min); US (5 min); SP (5 min after 2 min to establish a flow); SS (3 min).
ELISA
11014514
P22079 x
x 2,28 34-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
subjects were requested not to eat, drink or perform oral hygiene measures after midnight the night before saliva collections. Unstimulated whole 
(UW) saliva, stimulated
parotid (SP) and stimulated (SS) and unstimulated (US) submandibular/sublingual saliva were collected from each subject between 8:00 and 10:00 
a.m. SP saliva was collected using a modified Carlson-Crittenden cup (13) and US and SS saliva was collected with a micropipette connected to a 
mini-vacuum pump (14). Salivary stimulation was
achieved by swabbing the lateral surfaces of the tongue with 0.1 mol/L (2% w/v) citric acid every 30 s. The sequence and times of collection of 
saliva was as follows: UW (5 min); US (5 min); SP (5 min after 2 min to establish a flow); SS (3 min).
ELISA
11014514
P05164 x
x 3,86 34-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
subjects were requested not to eat, drink or perform oral hygiene measures after midnight the night before saliva collections. Unstimulated whole 
(UW) saliva, stimulated
parotid (SP) and stimulated (SS) and unstimulated (US) submandibular/sublingual saliva were collected from each subject between 8:00 and 10:00 
a.m. SP saliva was collected using a modified Carlson-Crittenden cup (13) and US and SS saliva was collected with a micropipette connected to a 
mini-vacuum pump (14). Salivary stimulation was
achieved by swabbing the lateral surfaces of the tongue with 0.1 mol/L (2% w/v) citric acid every 30 s. The sequence and times of collection of 
saliva was as follows: UW (5 min); US (5 min); SP (5 min after 2 min to establish a flow); SS (3 min).
ELISA
11014514
P01876
x x 1,25 34-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
subjects were requested not to eat, drink or perform oral hygiene measures after midnight the night before saliva collections. Unstimulated whole 
(UW) saliva, stimulated
parotid (SP) and stimulated (SS) and unstimulated (US) submandibular/sublingual saliva were collected from each subject between 8:00 and 10:00 
a.m. SP saliva was collected using a modified Carlson-Crittenden cup (13) and US and SS saliva was collected with a micropipette connected to a 
mini-vacuum pump (14). Salivary stimulation was
achieved by swabbing the lateral surfaces of the tongue with 0.1 mol/L (2% w/v) citric acid every 30 s. The sequence and times of collection of 
saliva was as follows: UW (5 min); US (5 min); SP (5 min after 2 min to establish a flow); SS (3 min).
ELISA
11014514
P61626
x x 1,15 34-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
subjects were requested not to eat, drink or perform oral hygiene measures after midnight the night before saliva collections. Unstimulated whole 
(UW) saliva, stimulated
parotid (SP) and stimulated (SS) and unstimulated (US) submandibular/sublingual saliva were collected from each subject between 8:00 and 10:00 
a.m. SP saliva was collected using a modified Carlson-Crittenden cup (13) and US and SS saliva was collected with a micropipette connected to a 
mini-vacuum pump (14). Salivary stimulation was
achieved by swabbing the lateral surfaces of the tongue with 0.1 mol/L (2% w/v) citric acid every 30 s. The sequence and times of collection of 
saliva was as follows: UW (5 min); US (5 min); SP (5 min after 2 min to establish a flow); SS (3 min).
ELISA
11014514
P02788
x x 1,59 34-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
subjects were requested not to eat, drink or perform oral hygiene measures after midnight the night before saliva collections. Unstimulated whole 
(UW) saliva, stimulated
parotid (SP) and stimulated (SS) and unstimulated (US) submandibular/sublingual saliva were collected from each subject between 8:00 and 10:00 
a.m. SP saliva was collected using a modified Carlson-Crittenden cup (13) and US and SS saliva was collected with a micropipette connected to a 
mini-vacuum pump (14). Salivary stimulation was
achieved by swabbing the lateral surfaces of the tongue with 0.1 mol/L (2% w/v) citric acid every 30 s. The sequence and times of collection of 
saliva was as follows: UW (5 min); US (5 min); SP (5 min after 2 min to establish a flow); SS (3 min).
ELISA
11014514
P02768
x x 1,42 34-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
subjects were requested not to eat, drink or perform oral hygiene measures after midnight the night before saliva collections. Unstimulated whole 
(UW) saliva, stimulated
parotid (SP) and stimulated (SS) and unstimulated (US) submandibular/sublingual saliva were collected from each subject between 8:00 and 10:00 
a.m. SP saliva was collected using a modified Carlson-Crittenden cup (13) and US and SS saliva was collected with a micropipette connected to a 
mini-vacuum pump (14). Salivary stimulation was
achieved by swabbing the lateral surfaces of the tongue with 0.1 mol/L (2% w/v) citric acid every 30 s. The sequence and times of collection of 
saliva was as follows: UW (5 min); US (5 min); SP (5 min after 2 min to establish a flow); SS (3 min).
ELISA
11014514
Q9UBU3 x
x -2,10 38-66 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Subjects were asked not to eat, smoke or drink (except water) for an overnight fast prior to
collection of saliva samples. Their diets were similar with respect to protein content and uptake of fat and carbohydrates. Socioeconomical status 
was similar for both groups (survey data).
Ghrelin was measured in unstimulated total saliva using the same human-ghrelin-
RIA kit, which is designed to test any biological fluid with sufficient levels of the 
peptide to be determined. 17244479
Q9UBU3 x
x -1,32 38-66 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Subjects were asked not to eat, smoke or drink (except water) for an overnight fast prior to
collection of saliva samples. Their diets were similar with respect to protein content and uptake of fat and carbohydrates. Socioeconomical status 
was similar for both groups (survey data).
Ghrelin was measured in unstimulated total saliva using the same human-ghrelin-
RIA kit, which is designed to test any biological fluid with sufficient levels of the 
peptide to be determined. 17244479
Q9UBU3 x
x -1,63 38-66 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Subjects were asked not to eat, smoke or drink (except water) for an overnight fast prior to
collection of saliva samples. Their diets were similar with respect to protein content and uptake of fat and carbohydrates. Socioeconomical status 
was similar for both groups (survey data).
Ghrelin was measured in unstimulated total saliva using the same human-ghrelin-
RIA kit, which is designed to test any biological fluid with sufficient levels of the 
peptide to be determined. 17244479
89
Q9UBU3 x
x -1,23 38-66 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Subjects were asked not to eat, smoke or drink (except water) for an overnight fast prior to
collection of saliva samples. Their diets were similar with respect to protein content and uptake of fat and carbohydrates. Socioeconomical status 
was similar for both groups (survey data).
Ghrelin was measured in unstimulated total saliva using the same human-ghrelin-
RIA kit, which is designed to test any biological fluid with sufficient levels of the 
peptide to be determined. 17244479
P04745 x
x 1,25 38-66 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Subjects were asked not to eat, smoke or drink (except water) for an overnight fast prior to
collection of saliva samples. Their diets were similar with respect to protein content and uptake of fat and carbohydrates. Socioeconomical status 
was similar for both groups (survey data).
amylase activity
was determined by the colorimetric method of Winn-Deen and coworkers
17244479
P04745 x
x 1,24 38-66 MF
Non-smoker; Non-
alcoholic; no 
pregnancy
Subjects were asked not to eat, smoke or drink (except water) for an overnight fast prior to
collection of saliva samples. Their diets were similar with respect to protein content and uptake of fat and carbohydrates. Socioeconomical status 
was similar for both groups (survey data).
amylase activity
was determined by the colorimetric method of Winn-Deen and coworkers
17244479
P02768 x
x 1,19 45-64 MF
The study included 
patientes with 
habits of smoking 
and alcohol 
consumption
Subjects were told not to eat or smoke for one hour prior to the examination.
colorimetric
methods
11005153
P04745 x
x 1,14 45-64 MF
The study included 
patientes with 
habits of smoking 
and alcohol 
consumption
Subjects were told not to eat or smoke for one hour prior to the examination.
Boehringer MPR 3 a-amylase
EPS method
11005153
P05231 x
x 0,00 35-65 MF
Non-smoker; Non-
alcoholic; no 
pregnancy Subjects refrained from eating, drinking, and oral hygiene for 2 hours prior to saliva collection.
ELISA
20192865
90
Biological Process
Oraloma 
Normal
Diabetes 
esperado
Diabetes 
observado
Diferença 
fracional  P value
cell communication 544 6,598 13 0,97 0,007013492
cellular process 912 11,061 13 0,18 0,287905016
apoptosis 142 1,722 5 1,90 0,026555207
reproduction 109 1,322 1 -0,24 0,741568258
developmental process 469 5,688 3 -0,47 0,942642667
metabolic process 1307 15,852 11 -0,31 0,977046763
cell cycle 269 3,263 3 -0,08 0,648398234
immune system process 459 5,567 11 0,98 0,01466063
cell adhesion 219 2,656 1 -0,62 0,938322452
Total Oraloma normal 2391
Total Diabetes 1 29
-1,00
-0,50
0,00
0,50
1,00
1,50
2,00
2,50
Processo Biológico 

Função Molecular
Oraloma 
Normal
Diabetes 
esperado
Diabetes 
observado
Diferença 
fracional
binding 965 11,70431 15 0,28 0,1452
catalytic activity 946 11,47386 3 -0,74 0,999912
enzyme regulator activity 202 2,450021 5 1,04 0,093208
receptor activity 188 2,280217 3 0,32 0,401688
2391
29
-1,00
-0,50
0,00
0,50
1,00
1,50
binding catalytic activity enzyme regulator
activity
receptor activity
Função Molecular 

Pathway
Oraloma 
Normal
Diabetes 
esperado
Alzheimer disease-presenilin pathway 23 0,28
Apoptosis signaling pathway 23 0,28
Beta1 adrenergic receptor signaling pathway 16 0,19
Beta2 adrenergic receptor signaling pathway 16 0,19
5HT1 type receptor mediated signaling pathway 13 0,16
Endothelin signaling pathway 17 0,21
Enkephalin Release 13 0,16
GABA-B receptor II signaling 10 0,12
Hedgehog signaling pathway 3 0,04
2391 29,00
29 0,35
Gonadotropin releasing hormone receptor pathway 58 0,70
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway 29 0,35
Inflammation mediated by chemokine and cytokine signaling pathway 74 0,90
Interleukin signaling pathway 14 0,17
Histamine H2 receptor mediated signaling pathway 9 0,11
Interferon-gamma signaling pathway 4 0,05
Metabotropic glutamate receptor group I pathway 3 0,04
Metabotropic glutamate receptor group II pathway 16 0,19
Metabotropic glutamate receptor group III pathway 12 0,15
Muscarinic acetylcholine receptor 2 and 4 signaling pathway 16 0,19
Transcription regulation by bZIP transcription factor 4 0,05
Wnt signaling pathway 43 0,52
Devido ao nº elevado de Pathways relativo ao OralOma Normal (125) , apresentei apenas os comuns com a Diabetes
Diabetes 
observado
Diferença 
fracional
2 6,17 0,03
1 2,58 0,24
2 9,31 0,02
2 9,31 0,02
2 11,68 0,01
2 8,70 0,02
2 11,68 0,01
2 15,49 0,01
2 53,97 0,00
#####
#####
3 3,26 0,03
2 4,69 0,05
4 3,46 0,01
3 16,67 0,00
2 17,32 0,01
1 19,61 0,05
2 53,97 0,00
2 9,31 0,02
2 12,74 0,01
2 9,31 0,02
2 40,22 0,00
1 0,92 0,41
Devido ao nº elevado de Pathways relativo ao OralOma Normal (125) , apresentei apenas os comuns com a Diabetes 0,00
10,00
20,00
30,00
40,00
50,00
60,00
Pathways 

Biological Process
Oraloma 
Normal
Diabetes 
esperado
Diabetes 
observado
Diferença 
fracional  P value
cell communication 544 6,598 13 0,97 0,007013492
cellular process 912 11,061 13 0,18 0,287905016
apoptosis 142 1,722 5 1,90 0,026555207
reproduction 109 1,322 1 -0,24 0,741568258
developmental process 469 5,688 3 -0,47 0,942642667
metabolic process 1307 15,852 11 -0,31 0,977046763
cell cycle 269 3,263 3 -0,08 0,648398234
immune system process 459 5,567 11 0,98 0,01466063
cell adhesion 219 2,656 1 -0,62 0,938322452
Total Oraloma normal 2391
Total Diabetes 1 29
-1,00
-0,50
0,00
0,50
1,00
1,50
2,00
2,50
Processo Biológico 

Função Molecular
Oraloma 
Normal
Diabetes 
esperado
Diabetes 
observado
Diferença 
fracional
binding 965 11,70431 15 0,28 0,1452
catalytic activity 946 11,47386 3 -0,74 0,999912
enzyme regulator activity 202 2,450021 5 1,04 0,093208
receptor activity 188 2,280217 3 0,32 0,401688
2391
29
-1,00
-0,50
0,00
0,50
1,00
1,50
binding catalytic activity enzyme regulator
activity
receptor activity
Função Molecular 

Pathway
Oraloma 
Normal
Diabetes 
esperado
Alzheimer disease-presenilin pathway 23 0,28
Apoptosis signaling pathway 23 0,28
Beta1 adrenergic receptor signaling pathway 16 0,19
Beta2 adrenergic receptor signaling pathway 16 0,19
5HT1 type receptor mediated signaling pathway 13 0,16
Endothelin signaling pathway 17 0,21
Enkephalin Release 13 0,16
GABA-B receptor II signaling 10 0,12
Hedgehog signaling pathway 3 0,04
2391 29,00
29 0,35
Gonadotropin releasing hormone receptor pathway 58 0,70
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway 29 0,35
Inflammation mediated by chemokine and cytokine signaling pathway 74 0,90
Interleukin signaling pathway 14 0,17
Histamine H2 receptor mediated signaling pathway 9 0,11
Interferon-gamma signaling pathway 4 0,05
Metabotropic glutamate receptor group I pathway 3 0,04
Metabotropic glutamate receptor group II pathway 16 0,19
Metabotropic glutamate receptor group III pathway 12 0,15
Muscarinic acetylcholine receptor 2 and 4 signaling pathway 16 0,19
Transcription regulation by bZIP transcription factor 4 0,05
Wnt signaling pathway 43 0,52
Devido ao nº elevado de Pathways relativo ao OralOma Normal (125) , apresentei apenas os comuns com a Diabetes
Diabetes 
observado
Diferença 
fracional
2 6,17 0,03
1 2,58 0,24
2 9,31 0,02
2 9,31 0,02
2 11,68 0,01
2 8,70 0,02
2 11,68 0,01
2 15,49 0,01
2 53,97 0,00
#####
#####
3 3,26 0,03
2 4,69 0,05
4 3,46 0,01
3 16,67 0,00
2 17,32 0,01
1 19,61 0,05
2 53,97 0,00
2 9,31 0,02
2 12,74 0,01
2 9,31 0,02
2 40,22 0,00
1 0,92 0,41
Devido ao nº elevado de Pathways relativo ao OralOma Normal (125) , apresentei apenas os comuns com a Diabetes 0,00
10,00
20,00
30,00
40,00
50,00
60,00
Pathways 

Biological Process
Oraloma 
Normal
Diabetes 
esperad
o
Diabetes 
observado
Diferença 
fracional
 P 
value
apoptosis 127 22,780 24 0,05 0,43
cell adhesion 194 34,797 48 0,38 0,02
cell communication 503 90,221 101 0,12 0,11
cell cycle 237 42,510 39 -0,08 0,74
cellular component organization 304 54,527 37 -0,32 1,00
cellular process 843 151,206 141 -0,07 0,86
developmental process 411 73,720 64 -0,13 0,91
generation of precursor metabolites and energy 89 15,964 14 -0,12 0,73
homeostatic process 30 5,381 5 -0,07 0,63
immune system process 398 71,388 120 0,68 0,00
localization 27 4,843 4 -0,17 0,71
metabolic process 1261 226,181 250 0,11 0,01
reproduction 68 12,197 14 0,15 0,34
response to stimulus 286 51,299 84 0,64 0,00
system process 281 50,402 49 -0,03 0,61
transport 459 82,329 68 -0,17 0,97
Total Oraloma normal 2336
Total Diabetes 419
-0,40
-0,20
0,00
0,20
0,40
0,60
0,80
Processo Biológico 
Função Molecular
Oralom
a 
Normal
Diabetes 
esperad
o
Diabetes 
observado
Diferenç
a 
fracional  P value
antioxidant activity 16 2,87 8 1,79 0,01
binding 910 163,22 146 -0,11 0,96
catalytic activity 909 163,04 182 0,12 0,03
enzyme regulator activity 181 32,47 46 0,42 0,01
ion channel activity 27 4,84 3 -0,38 0,86
motor activity 30 5,38 2 -0,63 0,97
receptor activity 167 29,95 35 0,17 0,19
structural molecule activity 426 76,41 58 -0,24 0,99
transcription regulator activity 86 15,43 3 -0,81 1,00
translation regulator activity 45 8,07 4 -0,50 0,96
transporter activity 149 26,73 26 -0,03 0,59
Total Oraloma normal 2336
Total Diabetes 419
-1,00
-0,50
0,00
0,50
1,00
1,50
2,00
Função Molecular 
Pathway
Oraloma 
Normal
Diabetes 
esperado
Diabetes 
observado
Diferença 
fracional  P value
5-Hydroxytryptamine degredation 10 1,79 1,00 -0,44 0,83
Adenine and hypoxanthine salvage pathway 3 0,54 2,00 2,72 0,10
Alzheimer disease-amyloid secretase pathway 9 1,61 2,00 0,24 0,48
Alzheimer disease-presenilin pathway 22 3,95 4,00 0,01 0,56
Angiogenesis 28 5,02 3,00 -0,40 0,88
Angiotensin II-stimulated signaling through G proteins and beta-arrestin 15 2,69 3,00 0,12 0,50
Apoptosis signaling pathway 25 4,48 3,00 -0,33 0,83
Asparagine and aspartate biosynthesis 2 0,36 2,00 4,58 0,05
ATP synthesis 5 0,90 1,00 0,12 0,59
Axon guidance mediated by netrin 7 1,26 2,00 0,59 0,36
Axon guidance mediated by semaphorins 8 1,43 1,00 -0,30 0,76
Axon guidance mediated by Slit/Robo 8 1,43 1,00 -0,30 0,76
B cell activation 16 2,87 3,00 0,05 0,55
Blood coagulation 16 2,87 10,00 2,48 0,00
Cadherin signaling pathway 19 3,41 2,00 -0,41 0,86
Cytoskeletal regulation by Rho GTPase 50 8,97 7,00 -0,22 0,79
De novo purine biosynthesis 12 2,15 1,00 -0,54 0,88
Dopamine receptor mediated signaling pathway 25 4,48 1,00 -0,78 0,99
EGF receptor signaling pathway 35 6,28 8,00 0,27 0,29
Endothelin signaling pathway 16 2,87 2,00 -0,30 0,78
FAS signaling pathway 9 1,61 3,00 0,86 0,22
FGF signaling pathway 31 5,56 9,00 0,62 0,11
Fructose galactose metabolism 4 0,72 1,00 0,39 0,51
Glutamine glutamate conversion 3 0,54 1,00 0,86 0,42
Glycolysis 17 3,05 5,00 0,64 0,19
Gonadotropin releasing hormone receptor pathway 55 9,87 6,00 -0,39 0,93
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway 27 4,84 3,00 -0,38 0,86
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway 21 3,77 2,00 -0,47 0,89
Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction 10 1,79 1,00 -0,44 0,83
Huntington disease 59 10,58 9,00 -0,15 0,73
Inflammation mediated by chemokine and cytokine signaling pathway 74 13,27 12,00 -0,10 0,68
Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade 9 1,61 1,00 -0,38 0,80
Integrin signalling pathway 84 15,07 16,00 0,06 0,44
Interferon-gamma signaling pathway 3 0,54 1,00 0,86 0,42
Interleukin signaling pathway 13 2,33 2,00 -0,14 0,68
N-acetylglucosamine metabolism 2 0,36 1,00 1,79 0,30
Nicotine pharmacodynamics pathway 14 2,51 1,00 -0,60 0,92
Nicotinic acetylcholine receptor signaling pathway 36 6,46 1,00 -0,85 1,00
p38 MAPK pathway 9 1,61 2,00 0,24 0,48
p53 pathway 15 2,69 1,00 -0,63 0,93
Parkinson disease 36 6,46 18,00 1,79 0,00
PDGF signaling pathway 18 3,23 1,00 -0,69 0,96
Pentose phosphate pathway 5 0,90 2,00 1,23 0,23
Phenylalanine biosynthesis 2 0,36 2,00 4,58 0,05
PI3 kinase pathway 14 2,51 1,00 -0,60 0,92
Plasminogen activating cascade 8 1,43 4,00 1,79 0,06
Purine metabolism 1 0,18 2,00 10,15 0,01
Pyridoxal phosphate salvage pathway 1 0,18 1,00 4,58 0,16
Pyrimidine Metabolism 6 1,08 1,00 -0,07 0,66
Pyruvate metabolism 7 1,26 3,00 1,39 0,13
Ras Pathway 20 3,59 3,00 -0,16 0,70
Salvage pyrimidine deoxyribonucleotides 2 0,36 1,00 1,79 0,30
Salvage pyrimidine ribonucleotides 6 1,08 2,00 0,86 0,29
Synaptic_vesicle_trafficking 8 1,43 1,00 -0,30 0,76
T cell activation 20 3,59 5,00 0,39 0,29
TCA cycle 6 1,08 2,00 0,86 0,29
TGF-beta signaling pathway 9 1,61 2,00 0,24 0,48
Toll receptor signaling pathway 10 1,79 3,00 0,67 0,27
Tyrosine biosynthesis 2 0,36 2,00 4,58 0,05
Ubiquitin proteasome pathway 24 4,30 4,00 -0,07 0,62
Vasopressin synthesis 5 0,90 2,00 1,23 0,23
VEGF signaling pathway 12 2,15 2,00 -0,07 0,63
Vitamin B6 metabolism 1 0,18 1,00 4,58 0,16
Wnt signaling pathway 41 7,35 2,00 -0,73 0,99
Xanthine and guanine salvage pathway 2 0,36 2,00 4,58 0,05
Total Oraloma normal 2336
Total Diabetes 419
Devido ao nº elevado de Pathways relativo ao OralOma Normal (125) , apresentei apenas os comuns com a Diabetes
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Biological Process DMT2
DMT1 
esperado
DMT1 
observado
Diferença 
fracional  P value
cell communication 85 1,031 13 11,61 0,00
cellular process 118 1,431 13 8,08 0,04
apoptosis 22 0,267 5 17,74 0,02
reproduction 12 0,146 1 5,87 0,57
developmental process 52 0,631 3 3,76 0,72
metabolic process 221 2,680 11 3,10 0,96
cell cycle 33 0,400 3 6,50 0,40
immune system process 105 1,274 11 7,64 0,09
cell adhesion 37 0,449 1 1,23 0,93
response to stimulus 72 0,873 8 8,16 0,11
Total Oraloma normal 419
Total Diabetes 1 29
0,00
5,00
10,00
15,00
20,00
Processo Biológico 

Função Molecular DMT2
DMT1 
esperado
DMT1 
observado
Diferença 
fracional p-value
binding 146 1,7708072 15 7,47 0,05
catalytic activity 182 2,2074446 3 0,36 1,00
enzyme regulator activity 46 0,5579256 5 7,96 0,21
receptor activity 35 0,4245086 3 6,07 0,44
419
29
0,00
2,00
4,00
6,00
8,00
10,00
binding catalytic activity enzyme regulator
activity
receptor activity
Função Molecular 
Pathway DMT2
DMT1 
esperado
Alzheimer disease-presenilin pathway 4 0,05
Apoptosis signaling pathway 3 0,04
Endothelin signaling pathway 2 0,02
Gonadotropin releasing hormone receptor pathway 6 0,07
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway3 0,04
Inflammation mediated by chemokine and cytokine signaling pathway 12 0,15
Interleukin signaling pathway 2 0,02
Interferon-gamma signaling pathway 1 0,01
Wnt signaling pathway 2 0,02
419
29
Devido ao nº elevado de Pathways relativo ao OralOma Normal (125) , apresentei apenas os comuns com a Diabetes
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DMT1 
observado
Diferença 
fracional
2 40,22 0,03
1 26,48 0,19
2 81,45 0,01
3 40,22 0,01
2 53,97 0,02
4 26,48 0,01
3 122,67 0,00
1 81,45 0,07
1 40,22 0,13
